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Abstract 
Jenna Nicole Regan: Regulation of adventitia-resident progenitor cells 
(Under the direction of Mark W. Majesky) 
 
 
Far from the inert structural component that was the prevailing view for many years, 
the arterial adventitia is a region of active signaling that harbors Sca1+ vascular progenitor 
cells as well as many other cell types.  We have shown that a sonic hedgehog (Shh) 
signaling domain is restricted to the adventitial layer of artery wall beginning at embryonic 
day 15.5.  Hedgehog (Hh)-responsive cells, colocalize with a circumferential ring of Shh 
protein concentrated between the media and adventitia.  Furthermore, Sca1+ progenitor 
cells (AdvSca1 cells) reside within the Hh signaling domain and are reduced in number in 
Shh-/- mice.  As a population, AdvSca1 cells express transcription factors thought to be 
required for smooth muscle cell (SMC) differentiation, including serum response factor 
(SRF) and myocardin family members, yet the cells do not express SMC marker proteins in 
vivo.  However, upon removal of AdvSca1 cells from the adventitial environment, they 
readily differentiate to SMC-like cells in vitro.  Repression of SRF-dependent transcription 
may be mediated by SRF co-repressors such as Klf4, Msx1, and FoxO4, all of which are 
expressed by AdvSca1 cells in vivo.  Knockdown of Klf4 in AdvSca1 cells in vitro results in 
extensive down-regulation of Sca1 and defects in Sca1+ cell proliferation.  In vitro and in vivo 
experiments have shown that AdvSca1 cells possess the potential for SMC, pericyte/mural 
cell, adipogenic, ostogenic, endothelial, and macrophage differentiation.  Thus, AdvSca1 
cells are regulated, in part, by Hh signaling and the transcription factor Klf4 and function as 
progenitors for multiple cell types with physiological and pathological relevance to the artery 
wall.   
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Background 
 The mammalian hedgehog signaling pathway 
The hedgehog signaling network plays diverse roles in development.  Beginning with 
the identification of hedgehog and patch as Drosophila segment polarity mutants by 
Nüsslein-Volhard and Wieschaus in 1980 (1), investigation into the components and 
mechanisms of the hedgehog signaling network has drawn an increasingly complex and 
ever-evolving picture.  The components germane to this work will be briefly described, with 
mention of additional network components. 
Three mammalian homologues of the Drosophila hedgehog (Hh) gene have been 
identified:  Desert hedgehog, Indian hedgehog, and Sonic hedgehog (Dhh, Ihh, and Shh, 
respectively) (2).  Although all three proteins bind with similar affinity to Hh receptors, they 
vary in potency (3) and expression pattern (4), consistent with specialized functions during 
development.  Hh proteins undergo autocatalytic processing, resulting in an amino-terminal 
product with signaling activity.  The cleavage reaction also adds a cholesterol moiety to the 
amino-terminal domain (5, 6).   The amino-terminal signaling peptide is then further modified 
by the addition of a palmitoyl moiety, catalyzed by the acyltransferase Hhat in mammals.  
Together, these modifications contribute to the formation of soluble Hh protein multimers 
which, in turn, permit long-range Hh signaling (7, 8). 
Shh mutant mice exhibit a variety of defects, including brain, spinal cord, eye, 
skeletal, and limb development (9).  They also have abnormal neural crest cell development, 
leading to defects in arch artery and outflow tract patterning (10).  Only about half of the 
expected number of Shh-/- embryos survive to term, and none live past birth (11).  Similar 
survival rates are seen in Ihh-/- embryos, with about half dying around midgestation and the 
remainder perishing at birth due to respiratory failure.  Ihh-/- embryos exhibit pronounced 
skeletal defects, including forelimb and rib shortening, misshapen endochondral bones, and 
misformed joints (12).  In addition, Ihh signaling is critical for proper yolk sac angiogenesis, a 
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phenotype which will be further discussed below.  In contrast to the lethal phenotypes of 
Shh and Ihh knockouts, Dhh-/- mice are fully viable, although males are infertile due to 
defects in spermatogenesis (13). 
There are two mammalian homologues of the Hh receptor Patched, Ptc1 and Ptc2.  
Ptc proteins are 12-pass transmembrane proteins (14) with two large hydrophilic 
extracellular loops that mediate binding to Hh proteins (15).  In addition to functioning as 
receptors for Hh ligands, Ptc genes are also transcriptional targets of the Hh pathway and 
are thus upregulated in response to Hh signaling (14).  Therefore, Ptc expression is found in 
many tissues adjacent to the source of Hh signal.  Mouse Ptc2 protein shares 56% identity 
with Ptc1, with divergent regions including the intercellular amino- and carboxy-terminal 
sequences (16).  Although both Ptc proteins can bind Hh ligands, they do not function 
redundantly.  Their expression patterns only partially overlap (17, 18) and the knockout 
phenotype of Ptc1-/- mice is much more severe.  Ptc1-/- embryos die between embryonic day 
9 (E9.0) and E10.5, exhibiting an open neural tube, overgrown head folds, hindbrain, and 
spinal cord, and an abnormal heart (19).  In contrast, Ptc2-/- mice are viable, although they 
develop skin defects including alopecia and epidermal hyperplasia (20, 21).   
Although Ptc proteins serve as the receptors for Hh ligands, the downstream 
signaling is actually transduced by another transmembrane protein, Smoothened (Smo).  
Smo has seven transmembrane domains and bears some structural similarity to G protein-
coupled receptors (22, 23).  It is well-established that in the absence of Hh signaling, Ptc 
proteins exert a negative effect on Smo activity.  When Hh ligands bind to the Ptc receptors, 
it alleviates the repression and allows Smo to activate downstream signaling.  Exactly how 
Ptc exerts its repressive effects on Smo has been unclear for many years.  Most recent 
models favor a mechanism by which Ptc functions as a pump (the Ptc protein sequence 
shows some homology to the prokaryotic resistance-nodulation-division (RND) family of 
small-molecule pumps (24)).  The pumping action of Ptc may change the concentration or 
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localization of small molecules, such as oxysterols, which affect the activity of Smo (25-28).   
Smo knockout mice die by E9.5 with severe abnormalities, including failure to undergo 
embryonic turning, defects in closure of the ventral midgut and looping of the linear heart 
tube, ventral cyclopia, and holoprosencephaly (29). 
The ultimate effectors of Hh signaling in mice are the three Gli transcription factors 
(Gli1-3).  All three contain a series of five highly conserved C2H2 zinc fingers (30).  Like the 
Ptc genes, the Gli1 locus is also a transcriptional target of Hh signaling (31-33).  Gli1 
functions as a transcriptional activator, while Gli2 and Gli3 possess both activating and 
repressive domains.  However, the expression of Gli1 from the endogenous Gli2 locus 
rescues defects related to Shh signaling, suggesting that Gli2 functions primarily as an 
activator in vivo (34).  Although Gli3 seems to exert its strongest effects as a negative 
regulator of Hh-dependent gene expression (35), some evidence suggests that it has 
important activating functions as well (35-37).  In the absence of active Hh signaling, the 
Gli3 protein is proteolytically cleaved to an 83 kDa repressor form, and this process is 
inhibited in the presence of Hh ligand (38, 39).   
The combination of unique and redundant activities of the Gli factors makes it a 
challenge to interpret the phenotypes of knockout mice.  Surprisingly, mutant Gli1zfd/zfd mice 
(homozygous for a mutation that removes the Gli1 zinc finger domains, and thus the DNA 
binding activity) are viable and appear normal (40).  Gli2zfd/zfd mutants, however, exhibit 
perinatal lethality and have multiple developmental defects, including skeletal, neural, and 
lung malformations (36, 37, 40-42).  Spontaneous Gli3 mutants were originally designated 
Xt (or XtJ), for extra-toes, referring to the gross polydactyly and syndactyly phenotype 
observed in homozygotes (43).  In addition, Gli3-/- embryos display brain, skeletal, and lung 
defects, and none survive beyond postnatal day 2 (P2) (32, 37, 39, 43).   
Various genetic combinations of Gli alleles indicate some level of functional 
redundancy.  Despite the lack of a gross phenotype in Gli1zfd/zfd mice, the additional removal 
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of one copy of Gli2 (Gli1zfd/zfd;Gli2+/zfd) provokes phenotypes similar to Gli2zfd/zfd, although not 
as severe.  Gli1zfd/zfd;Gli3+/- double mutants phenotypically resemble Gli3-/- mice.  These 
results are consistent with Gli2, but not Gli3, compensating for loss of Gli1 function during 
development (40).  Mutations in Gli2 and Gli3 affect the development of many of the same 
systems/organs (skeletal, neural, lung).  Analysis of double mutants indicates that each has 
both shared and specific functions.  For example, Gli2 and Gli3 mutants both show 
disruptions in tooth and palate development, but otherwise affect different subsets of the 
skeletal system.  Gli2zfd/zfd;Gli3+/- mice show synergistic malformations in several skeletal 
elements, consistent with partially redundant functions of Gli2 and Gli3 during skeletal 
development (37).  Analogous synergistic effects have been observed in lung and foregut 
development (36). 
Multiple additional factors in the Hh signaling network which have been identified and 
described in the literature will not be discussed in detail here, as their specific significance to 
the work described herein is minimal.  However, any background on Hh signaling would be 
incomplete without at least a brief mention of the critical role of the primary cilium in pathway 
signal transduction.  The primary cilium is a non-motile structure that can be found on most 
cell types.  Cilium structure depends on a microtubule scaffold which is nucleated from the 
basal body and extends in a “9+0” configuration.  Proteins and vesicles are transported 
along the cilia by kinesin (anterograde) and dynein (retrograde) motors together with 
intraflagellar transport (IFT) complexes (44).  In 2003, a report by Huangfu et al first 
identified the requirement for IFT proteins in Hh signal transduction (45).  Recent work has 
shown that multiple Hh signaling pathway components are dependent on the primary cilium 
for proper regulation.  In the absence of Hh signaling, Ptc1 is localized to the membrane 
along the shaft and around the base of the cilium.  When Ptc1 binds Shh, it disappears from 
the cilium, whereupon Smo begins to localize and concentrate at the cilium (27, 46).  Other
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Figure 1.  Simplified schematic of mammalian hedgehog signaling.  When no hedgehog 
ligand is present, Ptc receptors are localized to the shaft and base of the primary cilium.  
Gli2 and Gli3 transcription factors are bound by suppressor of fused (Sufu), which prevents 
the proteins from being degraded (47).  In the absence of ligand stimulation, Gli3 undergoes 
limited proteolysis to the shorter repressor form (GliR), which blocks the transcription of Hh 
target genes.  When Hh ligands are produced, they undergo lipid modifications and 
aggregate into a multimeric protein complex.  Release of ligand from Hh-producing cells is 
assisted by Dispatched1 (Disp) (48, 49).  Hh binding to Ptc receptors causes them to move 
out of the primary cilium, whereupon Smo begins to localize and concentrate at the cilium.  
Downstream of activated Smo, activator forms of Gli transcription factors (GliA) enter the 
nucleus and regulate the expression of target genes. 
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Hh pathway components, such as Suppressor of Fused (Sufu) and the Gli transcription 
factors, are also found at the primary cilium.  Levels of Gli2 and Gli3 at the cilium increase 
following Hh ligand stimulation (47), and ciliary localization is required for proper activity of 
both the repressor and activator forms of Gli2 and Gli3 (50, 51).  Collection of pathway 
components at the cilium may therefore be a mechanism which a) facilitates Hh signal 
transduction by bringing pathway components into close proximity and b) provides an 
additional level of regulation by controlling the localization of specific factors. 
 
Hedgehog signaling in the vasculature 
As is evident from the variety of defects observed in mutant mice with disrupted Hh 
pathway function, proper Hh signaling is critical for multiple developmental processes.  
Among them, Hh signaling has been linked to both vasculogenesis and angiogenesis.  
Mouse embryos lacking Smo have severe defects in endothelial tube formation, despite 
normal numbers of angioblasts (52).   Ihh signaling is critical for proper yolk sac 
angiogenesis, involving assembly of endothelial cells and SMCs into functional channels.  
Ihh-/- yolk sacs display small, disorganized vessels at E10.5.  Smo-/- yolk sacs arrest at an 
even earlier stage, having failed to undergo any remodeling of the primitive vascular plexus 
(53).   
A relatively recent body of work indicates that Shh signaling also plays essential roles 
in the development and maintenance of the coronary vasculature.  Cells that comprise the 
coronary vessels (including endothelial cells, smooth muscle cells, and fibroblasts) are 
derived from the proepicardium during embryonic development.  When proepicardial cells 
contact the myocardium, they migrate as an epithelial sheet to form the epicardium, which 
covers the surface of the heart.  Myocardial-derived signals initiate epicardial epithelial-to-
mesenchymal transition (EMT) and the mesenchymal cells migrate through the matrix-rich 
subepicardial space, infiltrate the myocardial wall, and begin to assemble the coronary 
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plexus (54, 55).  Lavine et al. reported that Shh is expressed in the epicardium at E12.5 and 
E13.5, during a critical period of coronary plexus growth.  The Shh signal is received by 
perivascular and myocardial cells, which respond by upregulating Hh target genes, including 
Ptc1 and Vegf-A.  The production of VEGF ligands by perivascular and myocardial cells is 
necessary for proper development of the coronary arteries and veins, respectively (56, 57). 
Although vessels in adult mice do express components of the Hh signaling pathway, 
Ptc1-lacZ activity decreases by post-natal day 14 and is maintained at low levels through 
adulthood ((58) and Chapter II).  Remarkably, even this low level of signaling is critical for 
cardiac function in adult mice.  Concurrent genetic ablation of Hh signaling in 
cardiomyocytes and vascular smooth muscle cells caused severe cardiac dysfunction and 
loss of coronary microvasculature by five days (59).   The Shh signaling pathway can also 
be robustly upregulated in adult vasculature by the administration of exogenous Shh.  
Interestingly, the Shh-responsive cells in adult vessels have been identified as interstitial 
fibroblasts and adventitial cells.  In a mechanism similar to that observed in coronary 
development, the interstitial mesenchymal cells respond to Shh by upregulating angiogenic 
growth factors such as VEGF-1, angiopoietin-1, and angiopoietin-2 (58).  In mouse models 
of hind-limb ischemia, diabetic wound healing, and myocardial ischemia, delivery of Shh 
ligand promoted angiogenesis (58, 60, 61).   
 
Hedgehog signaling functions in progenitor cell maintenance and proliferation 
The involvement of Hh signaling in the establishment, survival, and proliferation of 
progenitor cells has been observed in multiple tissues both during development and in 
adulthood.  For example, progenitor cells in the adult liver can be identified by Ptc1 
expression.  When these cells are isolated and cultured, treatment with cyclopamine, which 
blocks Hh signaling, induces apoptosis (62).  There have also been reports linking Hh 
signaling to progenitor cell maintenance in the hippocampus and subventricular zone of the 
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brain (63), progenitor cell self-renewal in mammary epithelium (64), and progenitor cell 
proliferation in the gut (65), inner ear (66), and skin (67).  An elegant model was proposed 
by Yu et al. for regulation of smooth muscle cell (SMC) progenitors by Shh in the developing 
kidney and ureter.  They found that ureteral mesenchymal cells located immediately 
adjacent to a source of Shh protein were maintained in an undifferentiated state and that 
these cells were absent in mice that lacked Shh signaling in the ureter.  Furthermore, Shh 
also had a proliferative effect on SMC progenitors in the ureter, such that mice lacking 
ureteral Shh showed defective SMC differentiation (68). 
 
Vascular precursors during development 
The development of all blood vessels begins with a primitive vascular network that is 
assembled from endothelial cells (vasculogenesis), extended (angiogenesis), and 
extensively remodeled (69, 70).  Endothelial cells themselves arise from mesodermal 
progenitors known as angioblasts and hemangioblasts.  Multiple signaling pathways 
influence angioblast differentiation, including VEGF and basic fibroblast growth factor 
(bFGF) (69).  Endothelial cells undergo further differentiation, including the adoption of 
either an arterial or venous identity (70).   
A critical step in the maturation of nascent vessels is the addition of supporting mural 
cells.  Diffusible factors secreted by endothelial cells recruit nearby mesenchymal cells, 
which migrate toward and cluster around the endothelial tube.  Knockout mouse studies 
have shown that PDGF-B is critical for this process, as mice deficient in PDGF-B or 
PDGFRβ develop fatal hemorrhages due to mural cell deficits (71-73).  Mural cells have 
diverse embryonic origins, reflective of the local mesenchymal tissue from which they are 
recruited during development.  In vessels that develop into major arteries and veins, the 
mesenchymal cells differentiate into smooth muscle cells, which assemble into multiple 
layers around the vessel.  Mural cells known as pericytes associate with small vessels 
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(including arterioles, capillaries, and venules).  Pericytes usually form no more than a single, 
often discontinuous, layer around the endothelial tube (69, 74).   
   
Progenitors for cells of the postnatal vasculature 
In postnatal tissue, multiple triggers can elicit an angiogenic response.  Increasing 
evidence supports the idea that endothelial and mural cells incorporated during the growth 
of new vessels can derive not only from preexisting differentiated cells, but also from 
vascular progenitor cells found throughout the body.  Precursors for both endothelial cells 
and smooth muscle cells have been identified in the blood, bone marrow, and resident 
within tissues such as adipose, heart, skeletal muscle, and vessel wall (75).   
Endothelial progenitor cells (EPCs) were first isolated from the mononuclear cell 
fraction of adult peripheral blood on the basis of CD34 and Flk-1 expression (76).  
Circulating endothelial progenitor cells were subsequently found to be derived from 
mobilized bone marrow-resident progenitors (77).  Physiological stimuli such as exercise, as 
well as pathophysiological events like vascular injury and acute myocardial infarction, can 
provoke the mobilization of EPCs from the bone marrow (78).   In addition, there is evidence 
suggesting that non-bone marrow sources contribute substantial numbers of replacement 
ECs in transplant arteriosclerosis (79) and circulating EPCs in response to tissue ischemia 
(80).  In the latter study, liver and small intestine transplantation experiments indicated that 
these organs also harbor tissue-resident EPCs that can be mobilized into circulation, home 
to sites of ischemia, and contribute to tissue repair (80). 
Like EPCs, smooth muscle progenitor cells (SMPCs) have been identified both in the 
circulation and resident within tissue.  Unsurprisingly, the bulk of interest in SMPCs has 
centered on their contribution to disease states.  SMCs are a key component of vascular 
lesions in atherosclerosis, transplant arteriopathy, vein graft arterisclerosis, and restenosis 
 11 
after angioplasty (81).  However, the relative contribution of various sources of SMPCs 
remains controversial and may depend on the model in question (82). 
There have been several reports of putative SMPCs isolated from postnatal tissue 
according to various criteria.  Majka et al. isolated non-side population (SP) cells from 
skeletal muscle.  These non-SP cells had a spindle-shaped morphology and expressed 
smooth muscle α-actin, CD45, platelet derived growth factor (PDGF) receptor β, and 
variable levels of Sca1 and CD34, but did not express desmin.  The isolated cells 
differentiated to smooth muscle in vivo when transplanted into skeletal muscle undergoing 
injury-induced neovascularization.  A bone marrow transplantation assay indicated that the 
skeletal muscle non-SP cells were largely derived from bone marrow (83).  Progenitor cells 
with both endothelial and smooth muscle potential were isolated from the aortas of adult 
mice by Sainz et al.  In this study, the authors focused on SP cells isolated from the aortic 
media that expressed Sca1 and low levels of c-kit and CD34.  The arterial SP cells 
differentiated to SMCs in vitro in response to transforming growth factor β (TGF-β) or PDGF-
BB treatment and formed vascular-like structures when cultured on Matrigel (84).  There are 
reports of SMPCs resident within other tissues as well.  However, there is a general lack of 
consistency in the methods and criteria used to isolate tissue-resident SMPCs, consistent 
with some degree of heterogeneity among the different populations.   
 
The perivascular progenitor cell niche 
Recently, the model of a perivascular niche for various populations of progenitor cells 
has generated much interest and excitement.  Conceptually, it is an elegant design.  
Vessels penetrate all types of tissue throughout the body, thus progenitor cells positioned in 
a perivascular location would be perfectly positioned to move into the surrounding tissue, 
migrate along the “track” provided by the vessel, or enter the circulation for homing to a 
distant site.  Progenitor cells considered to reside in a perivascular niche may be found 
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closely apposed to the endothelial cells of the microvasculature or embedded within the 
multilayered wall of larger vessels.   
Pericytes, while traditionally considered a type of mural cell that closely associates 
with microvascular endothelial cells, are increasingly regarded as functional progenitors 
themselves.  Their differentiation potentials are strikingly similar to those reported for non-
bone marrow multipotent mesenchymal stromal cells (MSCs, also known as mesenchymal 
stem cells) (85).  Indeed, recent reports strongly support the idea that MSCs in multiple 
tissues localize to a perivascular region and may in fact be indistinguishable from pericytes 
(86-88).  Other types of tissue-resident progenitor cells have also been reported to reside 
within close proximity to blood vessels, including undifferentiated spermatogonia (89), 
muscle satellite cells (90), and self-renewing brain tumor stem cells (91).  In the latter two 
cases, depletion of capillary vessels reduced the number of progenitor cells, indicating that 
the perivascular region provides a critical niche environment for maintenance of normal 
progenitor cell function.  
Two examples of progenitor cells residing within the vascular wall of large arteries 
were provided by Hu et al. and Zengin et al.  In work published in 2004, Hu et al. reported 
that the aortic root adventitia of ApoE-/- mice harbored a significant population of Sca1+ 
smooth muscle progenitor cells (92).  These cells, which we have termed adventitial Sca1+ 
progenitor cells (AdvSca1 cells) are further discussed in Chapters 2 and 3.  A 
complementary study by Zengin et al. reported that CD34+ EPCs can be isolated from 
human internal thoracic arteries.   Interestingly, these cells were localized in a specific 
region just outside the external elastic lamina, between the media and adventitia, that the 
authors termed a “vasculogenic zone”.   Progenitors from the vasculogenic zone formed 
capillary sprouts ex vivo and also displayed macrophage differentiation potential (93).  The 
degree of relationship between AdvSca1 cells and human CD34+ cells of the vasculogenic 
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zone is unclear.  However, these studies highlight the adventitial layer of large arteries as an 
important progenitor cell residence. 
 
Structure and cellular composition of arterial adventitia 
Surrounding the outside of major vessels is the adventitial layer, which is found 
immediately adjacent to the external elastic lamina.  The adventitia is commonly portrayed 
as a loosely organized, extracellular matrix-rich layer of the vessel wall composed primarily 
of fibroblasts.  However, multiple cell types in addition to fibroblasts reside within the 
adventitia of normal arteries.  In large muscular arteries, endothelial cells and pericytes 
 
Figure 2.  Structure of the artery wall and cell types within the adventitia.   
 
within the adventitia form a microvasculature network, the vasa vasorum, that penetrates 
and nourishes the medial and intimal layers of the artery wall (94-96).  The adventitia is also 
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home to perivascular nerves, lymphatic vessels, resident monocytes, macrophages, B and T 
lymphocytes, and dendritic cells (97, 98).  Peridadventitial adipose tissue is found closely 
surrounding and interspersed with the adventitia.   
In comparison to the intima and media, the adventitia has historically received 
relatively little attention, thus our knowledge about the developmental timing and origins of 
adventitial cells is limited.  A 1997 study by Lee et al reported that in developing chicken 
aortas, the ratio of the number of medial cells to adventitial cells gradually increases 
between days 6 and 16 of embryonic development.  The proliferation rate in the two 
compartments exhibits a similar trend, with a media:adventitia ratio of 1:2 from days 6-12 
and 3:2 after day 16 (99).  The authors used various antibodies against smooth muscle 
marker proteins to delineate the media, and any surrounding cells were considered 
adventitia.  Thus, much is yet unknown about the behavior of any particular cell type in the 
adventitia, or how this vessel layer assembles in mammalian systems. 
 
Adventitial response to vascular injury and contribution to neointima 
Adventitial cells play a key role in vascular wall growth, remodeling, and defense 
against infection (95, 97).  Experimental data shows that the adventitia responds rapidly and 
dramatically to vascular injury and stress.  One of the earliest vascular responses to multiple 
forms of vascular insult is an increase in adventitial cell proliferation leading to increased 
adventitial density and development of neoadventitia.  This type of adventitial response has 
been observed in hypertension (100, 101), pulmonary hypoxia (102), and various injury 
models, including arterial flow reduction (103) and overstretch (104, 105).   
Another common adventitial response, particularly to vascular injury, is the adoption 
of a “myofibroblast” phenotype.  In these instances, phenotypic changes may include the 
expression of SMC marker genes, increased migration, and increased production of 
extracellular matrix proteins such as collagen.  In a balloon injury model of porcine coronary 
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arteries, adventitial cells in uninjured vessels are negative for smooth muscle α-actin 
(SMαA) expression.  However, at 7 and 14 days after injury cells within the adventitia exhibit 
strong SMαA staining (104).  A similar pattern is observed in rabbit carotid arteries after a 
balloon injury that does not disrupt medial elastic laminae.  At 4 days after injury, adventitial 
cells expressing SM22α were localized primarily in the inner region of the adventitia (105).   
Changes in vascular structure following injury or during atherosclerotic plaque 
development include both geometric changes in actual vessel diameter and the 
development of a neointima.  It is logical that the adventitia, being the outermost layer of the 
vessel wall, would play an important role in regulating changes in vessel diameter.  Indeed, 
this is supported by experimental evidence from Labinaz et al, who found that neoadventitia 
development precedes arterial contracture in balloon-injured porcine coronary arteries (106).   
More controversial is the question of whether adventitial cells can participate in 
neointima formation.  In injury models that provoke neointimal development, the results have 
been mixed.  Following mild balloon injury (no disruption of elastic laminae) in rabbit carotid 
arteries, the authors observed some adventitia-derived cells capable of penetrating the 
adventitia-media boundary, but did not find evidence that they contributed to neointima 
formation (105).  However, adventitia to neointima migration was observed in a model of 
severe injury with a complete disruption of the medial layer and exposure of adventitial cells 
to the lumen (107).  Perhaps the most direct evidence of endogenous adventitial cell 
participation in neointima formation comes from a study by Siow et al in which they directly 
labeled adventitial cells with adenoviral lacZ.  Following balloon injury (without medial 
dissection) in rat carotid arteries, β-galactosidase-positive cells moved through the medial 
layer and were found in the neointima by 7 days after injury (108).  The variation in results 
between individual studies could be attributable to differences in the model organism, 
arterial bed, severity of vascular injury, and method of adventitial cell labeling/detection.  A 
common assumption is that the adventitial cells contributing to the neointima began as 
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fibroblasts that have undergone a transition to a “myofibroblast” phenotype in response to 
injury.  Yet the labeling methods used are not specific to any particular adventitial cell type, 
thus we can not say conclusively that “myofibroblasts” are the only adventitial cells 
participating in neointima formation.   
 
Transcriptional regulation of smooth muscle cell gene expression 
As cells differentiate to SMCs during development, they begin to express markers 
characteristic of a SMC phenotype.  Common SMC marker genes include SMαA, calponin, 
SM22α, smooth muscle γ-actin, and smooth muscle myosin heavy chain (SM-MHC) (109).  
SMαA is one of the first genes to be expressed during SMC differentiation.  It is highly 
abundant in SMCs (up to 40% of total protein) (110) but is also expressed by other SMC-like 
cell types and is not considered a marker specific to fully differentiated SMCs.  At the other 
end of the spectrum is SM-MHC, which is highly selective for actual SMCs (111).   
The transcription of most smooth muscle marker genes is controlled by one or more 
CArG elements (transcription factor binding sites with a “CC(A/T-rich)GG” motif) found within 
promoter and/or intronic sequences.  CArG elements are bound by homodimers of the 
transcription factor serum response factor (SRF).  Structurally, SRF shares homology with 
members of the MEF2 family of transcription factors.  All include an N-terminal MADS box 
comprised of a DNA-binding domain, a dimerization domain, and an interface for protein-
protein interactions (112).  SRF is widely expressed and can regulate cardiac and skeletal 
muscle genes as well as growth-responsive genes such as c-fos (113).  SRF-null mice 
display severe gastrulation defects and do not develop mesoderm, illustrating the 
widespread importance of this transcription factor (114). 
Because SRF is not intrinsically specific for SMC genes, additional mechanisms of 
regulation must be present in order to achieve specificity and precise control of SMC gene 
transcription.  There is a growing list of proteins that interact with SRF to modulate its 
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transcriptional activity.  These can act as co-activators or co-repressors with regards to SMC 
gene transcription.  Some, such as mHox (115) and Nkx3.1 (116), influence SRF binding to 
CArG elements.  Others associate with the SRF dimer through formation of a ternary 
complex to either augment (ex. myocardin family members (117) and Csrp1 and -2 (118)) or 
inhibit (ex. Elk1 (119), Msx1 and -2 (120)) the transcriptional activity of SRF.  In the case of 
myocardin family members MRTF-A (MAL) and MRTB-B, the actin cytoskeleton serves as 
an additional point of control.  MRTF-A and –B bind to actin and are released for nuclear 
translocation (and thus interaction with SRF) by actin treadmilling (121-123).   
Other factors have been shown to act indirectly to inhibit SRF-dependent SMC gene 
expression.  For example, Foxo4 strongly interacts with myocardin, repressing its ability to 
serve as an SRF co-activator (124).  The Krüppel-like factor Klf4 also potently inhibits 
myocardin-induced activation of SMC genes, both by inhibiting myocardin expression (125) 
and potentially by recruiting histone deacetylases to regulatory regions of SMC genes (126). 
 
 
 
Figure 3.  Serum response factor and cofactors.  SRF binds as a homodimer to the 
consensus CArG element in target gene promoters.  The transcriptional activity is modulated 
by the interaction of co-activators and co-repressors, many of which associate with SRF 
itself through protein-protein interactions with the MADS domain.  The crystal structure of 
the SRF MADS domain was adapted from Pellegrini et al. (127). 
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Introduction and Specific Aims 
This research was conducted towards the overall goal of identifying molecular 
mechanisms that contribute to formation and maintenance of SMC progenitors in the 
adventitia of artery walls.  These precursor cells, which we term AdvSca1 cells, have only 
recently been recognized as a novel source of SMCs in adult vessels.  We hypothesized 
that paracrine mechanisms which maintain these cells as SMC progenitors are active within 
a novel signaling domain in the adventitial layer of blood vessels in vivo.  We found that 
Sonic hedgehog (Shh) signaling is localized to this domain.  Moreover, AdvSca1 cells are 
significantly reduced in number in Shh knockout mice.  Wild-type AdvSca1 cells do not 
express SMC markers in vivo, yet they differentiate to SMC-like cells when removed from 
their native signaling environment in the artery wall.  Despite the absence of SMC marker 
expression, a subset of AdvSca1 cells express serum response factor (SRF) and myocardin, 
factors thought to be sufficient for expression of many SMC marker genes.  Unlike SMCs, 
AdvSca1 cells also express potent transcriptional repressors of SRF/myocardin-dependent 
transcription, including the Krüppel-like zinc finger factor Klf4.  These data are consistent 
with a model in which AdvSca1 cells in vivo are poised to become SMCs, but are kept in an 
undifferentiated state by transcriptional silencers that prevent the expression of SMC marker 
genes.  In addition, AdvSca1 cells are capable of propagating while maintaining a progenitor 
phenotype.  Thus, mechanisms regulating the self-renewal of AdvSca1 cells must also be 
present.  In addition to examining the role of Hh signaling in regulation of AdvSca1 cells, we 
have characterized their differentiation potential in vitro and in vivo and investigated the role 
of the transcriptional co-repressor Klf4 in regulating AdvSca1 self-renewal and SMC 
differentiation.   
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Specific Aim 1: Examine Shh signaling in the adventitia and test for a relationship 
between Shh signaling and the presence of adventitial Sca1+ progenitor cells. 
 
Specific Aim 2: Evaluate the progenitor potential and transcriptional regulation of 
AdvSca1 cells in vitro and in vivo. 
 
Specific Aim 3: Determine if maintenance of undifferentiated AdvSca1 cells depends 
on the transcriptional co-repressor Klf4. 
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CHAPTER 2 
A sonic hedgehog signaling domain in the arterial adventitia  
supports resident Sca1+ progenitor cells
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Introduction 
An adventitia surrounds most blood vessels where it functions as a dynamic 
compartment for cell trafficking into and out of the artery wall.  The adventitia is a site for 
formation and regression of microvessels that penetrate and nourish the medial and intimal 
layers of vessel wall (1-3).  The adventitia also contains perivascular nerves and lymphatic 
vessels and is an important domain for NAD(P)H oxidase activity in the vessel wall (4).  
Adventitial cells participate in vascular growth and repair and are important determinants of 
lumen size via control of inward or outward wall remodeling processes (2, 5).  Recent 
studies report unexpected roles for the adventitia insofar as it supports resident progenitor 
cells that can adopt both vascular and nonvascular fates (6-8).  Despite these important 
functional properties, the signals and environmental cues that confer such unique and 
dynamic properties to the adventitial layer remain largely unknown. 
Sonic hedgehog (Shh) is an essential morphogen and growth factor for many 
developing tissues (9).  In the vascular system, Shh signaling is important for specification of 
arterial-venous identity of endothelial cells (10), remodeling of yolk sac blood vessels (11), 
and recruitment of mural cells (12).  In adult blood vessels, Shh is angiogenic in ischemic 
hindlimb and corneal micropocket assays (13, 14), promotes perineural neovascularization 
in diabetic animals (15), and protects the myocardium against chronic ischemia (16).  Shh 
stimulates production of angiogenic factors, including VEGF-A and angiopoietin-1 by 
interstitial fibroblasts (13, 14), and promotes endothelial cell chemotaxis and tube formation 
(17, 18).  Therefore, Shh plays important roles in cell-cell communication during vascular 
development and adult wound repair. 
Hedgehog (Hh) proteins signal by binding to Patched-1 (Ptc1) or Patched-2 (Ptc2) 
receptors and Cdo/Boc accessory proteins at the cell surface, resulting in derepression of 
Smoothened (Smo) (19).  Ptc proteins are 12-transmembrane domain receptors that are 
structurally related to the resistance-nodulation-division (RND) family of bacterial membrane 
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permeases (20) and the Niemann-Pick C1-like1 cholesterol transporter (21).  Ptc proteins 
contain a conserved sterol-sensing domain, and recent studies suggest that Ptc1 represses 
Smo by transporting activating sterols out of the cell (22).  Hh binding to Ptc1 inhibits 
transporter activity, thereby allowing activating sterols to accumulate (19, 21).  Activated 
Smo traffics into the primary cilium where Hh signal mediators are concentrated (23, 24) and 
triggers phosphorylation of Gli factors that then move to the nucleus and stimulate gene 
transcription (25).  Among Hh target genes are Ptc1, Ptc2, and Gli1.  Therefore, Ptc1-lacZ, 
Ptc2-lacZ, and Gli1-lacZ activities are used as sensitive reporters of Hh signaling in 
transgenic mice (26-28). 
The origins and functions of the adventitia are poorly understood.  Hu et al. (6) 
reported that stem cell antigen-1 (Sca1)-positive cells with a potential to differentiate into 
smooth muscle cells (SMCs) were found in the aortic adventitia of adult ApoE-/- mice 
(AdvSca1 cells).  When transferred to the adventitial side of experimental vein grafts, 
AdvSca1-derived SMCs made up 30% of cells in the graft neointima after 4 weeks (6).   
The adventitia responds to balloon catheter injury with rapid increases in SMα-actin 
(SMαA) and SM22α expression (29, 30).  Endothelial progenitor cells are reported to cluster 
between the media and adventitia in human arteries (7, 8).  These cells formed capillary 
sprouts in ex vivo ring culture assays and were recruited by tumor cells for capillary vessel 
formation in vivo.  Given the role of Shh signaling in the maintenance of resident stem and 
progenitor cells in skin (31), nervous system (32), lymphoid tissue (33), and hematopoietic 
cells (34), we sought to test for similar roles for Hh signaling in the adventitial tissue 
surrounding blood vessels. 
 
Hypothesis 
Active Shh signaling in the adventitia contributes to the proper development of the 
adventitia and to maintenance of adventitial Sca1+ SMC progenitors. 
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Materials and Methods 
Animals Used:  All protocols were approved by the Institutional Animal Care and Use 
Committee at the University of North Carolina.  Mice used include Ptc1-lacZ (Ptch1tm1Mps, 
Jackson Laboratories; 003081, described in (26)), Ptc2-lacZ (Ptc2tm1Dgen; Jackson 
Laboratories; 005827), Gli1-lacZ (Gli1tm2Alj; Jackson Laboratories; 008211), Shhtm1Amc 
(Jackson Laboratories; 003318), 129/SvEvJ and C57BL/6J (Jackson Laboratories).  Noon 
on the day of vaginal plug was designated E0.5. 
β-Galactosidase Assay:  Embryos or tissues were fixed in fresh 0.2% glutaraldehyde 
and stained with a solution containing 5 mM potassium ferricyanide, 5 mM potassium 
ferrocyanide, and 1 mg/ml X-gal substrate at 37°C overnight.  Postfixation was performed in 
4% paraformaldehyde (PFA) at 4°C overnight.  For histological analysis, tissue was 
dehydrated, cleared (Histo-Clear; National Diagnostics), embedded in paraffin, sectioned, 
and counterstained with nuclear fast red (Vector Laboratories). 
Immunofluorescence Staining:  Tissues were fixed for 1 hr in freshly prepared 4% 
PFA, rinsed in PBS, saturated with 20% sucrose for cryoprotection, embedded in agar, and 
frozen in OCT.  Twelve-micrometer cryosections were fixed in methanol at room 
temperature for 5 min, permeabilized with 0.05% Tween-20 (in PBS) for 2 min, rinsed in 
PBS, then blocked in 2% normal goat serum (NGS) or normal donkey serum for 2–8 h.  
Sections were incubated with primary antibodies at 4°C overnight, rinsed twice in PBS + 
0.1% BSA, then incubated with secondary antibodies for 2–8 h at room temperature, 
protected from light.  Nuclei were counterstained with 10 μg/ml Hoechst 33258 in H2O and 
slides were mounted in Mowiol with 2.5% DABCO. 
Primary antibodies used for these studies included rabbit anti-β-galactosidase 
(1:500; MP Biomedical 55976), goat anti-Shh (1:100; R&D Systems AF445), rabbit anti-Dhh 
(1:100; Santa Cruz Biotechnology sc13089), rabbit anti-SM-MHC (1:100; Biomedical 
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Technologies BT-562), mouse anti-SMαA (1:100; Sigma A2547), rat anti-Sca1 (1:100; BD 
Pharmingen 553333), rabbit anti-Ihh (1:100; Santa Cruz Biotechnology sc13088), and rat 
anti-PECAM-1 (1:100; BD Pharmingen 550274).  All secondary antibodies were AlexaFluor-
conjugated (Invitrogen) and used at a dilution of 1:400 in PBS.  Immunofluorescence 
staining was visualized with a Leica BM IRB inverted epifluorescence microscope, with 
images captured by a QImaging Retiga 1300 digital camera.  Confocal images were 
obtained with a Zeiss LSM5 Pascal laser scanning confocal microscope and processed with 
Image J and Adobe Photoshop. 
RT-PCR Analysis:  Total cellular RNA was isolated by guanidinium isothiocyanate 
denaturation and phenol/chloroform extraction as described (35). Two-step RT-PCR was 
carried out with the GeneAmp RNA PCR kit (Applied Biosystems) according to the 
manufacturer’s instructions.  The sequences for primers used for RT-PCR analysis of gene 
expression are provided in Appendix B.  Unless otherwise indicated, primer sequences were 
designed for this study based on mouse genomic sequence available through Ensembl 
(release 45, June 2007; (36)). Primers were designed with the aid of Primer3 software (v. 
0.4.0) (37).   
AdvSca1 Cell Count from Shh-/- Embryos:  Embryos were isolated at E18.5.  The 
aorta was isolated and divided by anatomical region into ascending and descending portions 
(see schematic in Figure 11E).  Shh-/- embryos were pooled and matched to a control group 
comprised of an equal number of WT littermates.  Tissue was digested with 14 mg/ml 
collagenase type 2 (Worthington) and 0.75 mg/ml elastase (Roche) in HBSS for 2 h at 37°C 
with gentle rocking. The cell suspension was filtered (70 μm), and cells in the filtrate were 
pelleted at 300xg, rinsed in PBS+0.5% BSA, and counted. Sca1+ cells were isolated by 
using anti-Sca1 immunomagnetic MicroBeads and a MACS cell separation system 
(Miltenyi). The number of isolated Sca1+ cells was determined and compared with initial cell 
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counts to calculate the fraction of Sca1+ cells.  This experiment was repeated twice with 
similar results.  Error bars show standard error of the mean.   
Cyclopamine treatment of AdvSca1 cells in culture:  Sca1+ cells were isolated from 
the adventitia according to standard protocol.  Cells were cultured for 3 days to allow 
attachment and then cyclopamine (TRC, C988400) was added to a final concentration of 20 
μM.  Medium containing 0.4% DMSO was used as a vehicle control.  Cells were cultured for 
an additional 7 days, and 10 μM BrdU (BD Pharmingen, 550891) was added to culture 
medium 24 hrs before fixation.   
 
Results 
Hedgehog signaling in postnatal blood vessels 
We examined β-gal activity in blood vessels of Ptc1-lacZ, Ptc2-lacZ, and Gli1-lacZ 
knock-in mice at various developmental timepoints.  LacZ activity in the aortic root and 
coronary arteries was first detectable at embryonic day 15.5 (E15.5), with the strongest 
signal present at early postnatal timepoints.  In whole-mount hearts at postnatal day 2 (P2), 
lacZ activity was clearly present in coronary arteries, but not in myocardium or epicardium 
(Figure 4A-C).  The ascending aorta and pulmonary trunk were strongly positive at this time 
(Figure 4A-C).  Both Ptc1-lacZ and Ptc2-lacZ activities declined with age and were detected 
at low levels in coronary arteries and transverse aorta from adult mice (Figure 4D-E).  In 
contrast, Gli1-lacZ signal in coronary arteries, aorta, and pulmonary trunk remained robust 
into adulthood (Figure 4F). 
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Figure 4.  Hedgehog signaling in coronary and outflow tract arteries.  Whole hearts were 
isolated from Ptc1-lacZ (A, D), Ptc2-lacZ (B, E), or Gli1-lacZ (C, F) mice at either postnatal 
day 2 (P2; A-C) or adult (D-E) timepoints.  At P2, the aorta, pulmonary trunk, and coronary 
arteries exhibit strong β-galactosidase activity driven by all three promoters.  By adult 
stages, the number of cells with active Ptc1 and Ptc2 gene expression has decreased 
dramatically, while Gli1 continues to be expressed. 
 
Ptc1-, Ptc2-, and Gli1-lacZ activity was present throughout the body in large and 
medium-sized arteries, including mesenteric (Figure 5A-C), intercostal (Figure 5D-F) and 
femoral (Figure 5G-I) arteries.  In the mesenteric arcade, lacZ staining of arteries was more 
intense than that of veins (Figure 5A-C), whereas lymphatic vessels were negative.  In 
cross-sections of the aortic root and coronary arteries at P2, it is apparent that the majority 
of lacZ activity is restricted to the adventitia, with only an occasional positive cell found in the 
media or intima (Figure 6).  Thus, active Hh signaling is found in large and medium-sized 
arteries and veins in the perinatal period and is localized to the adventitia of these vessels.
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Figure 5.  Hedgehog signaling in other arterial beds.  Tissue was isolated from Ptc1-lacZ (A, 
D, G), Ptc2-lacZ (B, E, H), or Gli1-lacZ (C, F, I) mice at P2 and stained with X-gal.  All major 
arteries examined, including mesenteric (A-C), intercostal (D-F), and femoral (G-I), were 
positive for lacZ expression.  V, vein; A, artery; ica, intercostal artery; N, nerve. 
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Figure 6.  Hedgehog-responsive cells in the adventitia of major arteries.  Tissue from Ptc1-
lacZ (A, C, E) and Ptc2-lacZ (B, D, F) mice at P2 was isolated and stained with X-gal.  
Cross-sections through the aorta (A-B, E-F), pulmonary trunk (A-B), and coronary arteries 
(C-D) reveal that Hh-responsive lacZ+ cells are restricted to the adventitia during early 
postnatal development.  Staining patterns in Gli1-lacZ mice (not shown) were virtually 
identical.  PT, pulmonary trunk; Ao, aorta. 
 
Sonic hedgehog in the arterial adventitia 
Shh protein was localized to the interface between the media and adventitia in large 
and medium-sized arteries at 2 days after birth (Figure 7).  This pattern of Shh distribution 
colocalized with Ptc1-lacZ (Figure 7B, inset) and Ptc2-lacZ activities.  We could not detect 
Indian hedgehog (Ihh) in postnatal arteries and found only low levels of desert hedgehog 
(Dhh) in the endothelium (data not shown).  These results indicate that Ptc1-lacZ and Ptc2- 
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Figure 7.  Distribution of Shh and Sca1+ cells in the adventitia.  (A) Shh protein is found 
outside the aortic external elastic lamina (marked by green autofluorescence) at P2.  (B) 
Shh protein (red) is found between the media (SMα-actin, green) and adventitia of 
descending aorta.  (B, inset) Shh (red) is colocalized with β-gal in aortic sections from Ptc1-
lacZ mice.  (C) Sca1+ cells (red) reside outside the media (SMα-actin, green) in P2 aorta.  
(D) Sca1+ cells (green) are found in close proximity to Shh (red) and are embedded within a 
β-gal-positive domain (inset) in aortic adventitia from Ptc1-lacZ mice.  (E) Mesenteric 
vessels stained for SMα-actin (green) and Shh (red).  (F) Femoral arteries stained for SMα-
actin (green) and Sca1 (red).  Images are stacked Z-plane sections from confocal 
microscopy.  Adventitial localization of Sca1+ cells correlates with the distribution of Shh 
protein and active Shh signaling in vivo. 
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lacZ activities in the artery wall correlate with localized deposition of Shh protein in a 
circumferential ring in the extracellular matrix (ECM)-rich space between the media and 
adventitia. 
Despite the localization of Shh protein at the media/adventitia interface, Ptc1-, Ptc2-, 
and Gli1-lacZ activity suggests that only adventitial cells are Hh-responsive.  We tested the 
expression of Hh receptors and co-receptors in isolated adult medial or adventitial cells by 
RT-PCR (Figure 8).  The expression of Ptc1, Ptc2, Cdo, and Boc is significantly higher in 
adventitial cells than in media.   
 
Figure 8.  Expression of hedgehog pathway components in media and adventitia.  RNA was 
isolated from adult aortic media (M) or adventitia (A) and used for RT-PCR.  Key hedgehog 
signaling factors are more highly expressed in the adventitia. 
 
 
Sca1+ cells in the adventitia 
A previous report (6) described Sca1+ cells in the adventitia surrounding the aortic root 
in adult ApoE-/- mice.  One possible role of Shh may therefore be to maintain Sca1+ 
progenitor cells within this domain of artery wall.  To gain insight into the development of 
AdvSca1 cells in artery walls in vivo, we examined mice from embryonic day 12.5 (E12.5) to 
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Figure 9.  AdvSca1 cells in developing aorta.  (A–F) Tissues were obtained at the time 
points indicated.  Cross-sections through the aortic root were stained for Sca1 (red), SMα-
actin (green), and DAPI (blue).  In the adventitial space between the aorta and pulmonary 
trunk, AdvSca1 cells first appear between E16.5 and E17.5 (white arrow in B) and persist in 
this location into adulthood.  Ao, aorta; PT, pulmonary trunk.  
 
 
12 weeks after birth.  In the perivascular space between the ascending aorta and pulmonary 
trunk, AdvSca1 cells first appeared between E16.5 and E17.5 (Figure 9B, arrow).  This is 
well after the SMCs of the tunica media are established, which is evident by E15.5 (Figure 
9A).  AdvSca1 cells were present within the adventitia at the aortic root at all subsequent 
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time points examined, and they increased in number with postnatal growth of the artery wall 
(Figure 9C–F).  As shown in Figures 7 and 9, Sca1+ cells are restricted to the adventitia 
(AdvSca1 cells) and exhibit little or no overlap with SMα-actin-positive cells in the media.  A 
similar distribution was found in mesenteric and femoral arteries (Figure 7F and data not 
shown).  Close proximity was found between Shh protein and AdvSca1 cells (Figure 7D).  
Extensive overlap was observed between β-gal-positive cells and AdvSca1 cells in the aortic 
adventitia of Ptc1-lacZ mice (Figure 7D, inset).  These findings suggest that a zone of Shh 
signaling in the adventitia identifies a unique domain of artery wall within which resident 
Sca1+ vascular progenitor cells are found in vivo. 
AdvSca1 cells were isolated by immunoselection and examined for progenitor cell 
markers.  AdvSca1 cells exhibited a CD34+/c-kitlow/CD140b+ marker profile (Figure 10A) and 
were negative for CD45 and CD68 (data not shown), similar to the profile reported by Hu et 
al. (6).  Freshly isolated AdvSca1 cells consistently expressed markers of Shh signaling 
including Ptc1, Ptc2, Smo, Gli1, Gli2, and Gli3 (Figure 10B).  The distribution of Shh in the 
extracellular space is governed by multiple binding and transport proteins including 
hedgehog interacting protein-1 (Hhip1), Cdo, and Boc (reviewed in (19)), all of which are 
expressed by AdvSca1 cells (Figure 10B).  In addition, AdvSca1 cells contain mRNA for Shh 
and Dhh, with few, if any, transcripts detectable for Ihh (Figure 10B).  These results suggest 
that AdvSca1 cells both produce and respond to Shh, and that the restricted distribution of 
Shh in the artery wall is, in part, locally controlled by factors produced by AdvSca1 cells 
themselves. 
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Figure 10.  Expression profile of isolated AdvSca1 cells.  RT-PCR analysis of (A) common 
stem cell markers and (B) hedgehog pathway components in immunomagnetically isolated 
AdvSca1 cells from adult mice.  Components of a functional Hh signaling network are 
present in AdvSca1 cells.   
 
 
Analysis of AdvSca1 cells in Shh-/- mice 
To determine whether Shh was required for the formation or maintenance of 
AdvSca1 cells, we examined Shh-/- mice.  Two anatomically defined sites were studied at 
E18.5, as Shh mutants do not survive birth.  The presence of AdvSca1 cells at the aortic 
root, where they are abundant both during development and in adult mice (Figure 9 and (6)), 
was confirmed in wild-type mice (Figure 11A).  By contrast, we could not detect AdvSca1 
cells at the aortic root in Shh-/- embryos (Figure 11B).  A small number of AdvSca1 cells 
were found in the transverse portion of thoracic aorta (Figure 11F).  An absence of septation 
of the common truncus arteriosus in Shh-deficient embryos has been described (38).  
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AdvSca1 cells were present in the descending thoracic aorta of Shh-/- embryos, but always 
in reduced numbers (Figure 11D, F).   
 
 
 
Figure 11.  AdvSca1 cells in Shh-/- arteries.  (A–D) Aortic tissues from WT (A and C) and 
Shh-/- (B and D) embryos at E18.5.  Cross-sections through aortic root (A and B) and 
descending aorta (C and D) were immunostained for Sca1 (red), SMα-actin (green), and 
DAPI (blue).  (E) Solid lines indicate relative positions of sections in A–D.  (F) Dotted line 
boxes in E correspond to aortic segments shown here.  AdvSca1 cells are absent in aortic 
root, greatly reduced in ascending and transverse aorta (termed ascending), and diminished 
in descending aorta of Shh-/- embryos.   
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In addition to AdvSca1 cells, multiple other cell types within the adventitia may be 
dependent on active Hh signaling during early development for proper establishment, 
maintenance, and/or function.  In order to determine whether Shh-/- embryos exhibit a 
widespread defect in aortic adventitia development, we examined cross-sections through 
the aortic root.  In regions where AdvSca1 cells are absent in Shh-/- vessels, adventitial 
cells are present in numbers comparable to wild-type vessels (Figure 12, compare C and D).   
 
 
 
Figure 12.  Development of aortic adventitia in Shh-/- mice.  (A and C) Aortic root images 
from wild type mice at E18.5.  The boxed segment in A is shown at higher magnification in 
C. The adventitia is identified as DAPI-positive nuclei (blue, indicated by white arrows) 
outside the SMα-actin-positive medial layer (green).  Although the adventitial layer is still 
forming at E18.5, a similar number of DAPI-positive nuclei are found in the adventitia 
surrounding the aortic root in both WT (A and C) and Shh-/- mice (B and D).  wt, wild type; 
Ao, aorta; PT, pulmonary trunk 
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 The reduced numbers of AdvSca1 cells observed in Shh-/- vessels could be the 
result of defective recruitment of AdvSca1 cells from extravascular sites, a decrease in 
AdvSca1 cell proliferation within the adventitia, or a defect in AdvSca1 cell survival.  We 
used cyclopamine, a small-molecule inhibitor of Smo activity, to test the response of 
AdvSca1 cells to Hh signaling blockade in vitro.  Addition of cyclopamine to cell culture 
medium caused a drastic decrease in AdvSca1 cell numbers (Figure 13A-C).  The 
proliferation index of AdvSca1 cells in the presence of cyclopamine is decreased by ~50%, 
as measured by BrdU incorporation (Figure 13D).  There was no increase in apoptosis 
levels by TUNEL assay (data not shown).   
  
 
 
Figure 13.  Cyclopamine treatment of AdvSca1 cells in vitro.  (A-B) Isolated Sca1 cells were 
cultured under standard conditions (A) or with the addition of 20 μm cyclopamine (B).  
Immunofluorescence staining highlights the difference in overall cell numbers between 
culture conditions.  The change in cell number (C) can be attributed to a reduction in the 
proliferation of AdvSca1 cells, as measured by BrdU incorporation (D).   
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Discussion 
Hedgehog signaling in the artery wall 
Ptc1-lacZ and Ptc2-lacZ activities in the adventitia of large and medium-sized 
arteries were greatest between 1 and 10 days after birth.  Although the basic structure of 
major arteries is established at birth, substantial growth and remodeling occur in the 
perinatal period.  For example, the number of SMCs in rat aorta increases 2.5-fold, wall 
thickness doubles, and collagen and elastin contents increase ~3-fold in the first month after 
birth (39).  These changes in wall structure are adaptations to large perinatal increases in 
blood flow and blood pressure that are accompanied by corresponding increases in smooth 
muscle contractile protein mass (40).  After 3 months of age, growth of the artery wall is 
diminished, cell proliferation rates are low, and wall structure has reached an adult state.  
We found Ptc-lacZ activities and Shh protein levels were maintained at low levels in adult 
mouse arteries, suggesting that robust adventitial Shh signaling activity correlates with rapid 
postnatal growth and remodeling of the artery wall. 
At this time, we can only speculate about the mechanisms that maintain robust Gli1-
lacZ expression in the adventitia of adult arteries, at a time when Ptc1- and Ptc2-lacZ levels 
are at a low baseline.  A similar phenomenon was reported in a genetically-induced model of 
mouse prostate cancer.  During tumor progression from 6-16 weeks, the expression of both 
Shh and Ptc1 was significantly decreased.  In contrast, Gli1 expression was not significantly 
altered (41).  Further evidence supports the notion that Gli1 expression may differ from other 
Hh reporter genes, such as Ptc1 and Ptc2, due to regulation by Hh-independent 
mechanisms.  Nolan-Stevaux et al. generated mice with a genetic ablation of Smo in the 
pancreatic epithelium.  Surprisingly, the expression levels of Gli1 and Ptc1 in the pancreatic 
ducts were not significantly affected by the loss of Smo activity.  Based on a previous report 
that TGF-β signaling can induce the expression of Gli1 and Gli2 (42), the authors tested the 
effects of TGF-β treatment of Smo-/- cells in vitro.  Both Gli1 (4.5-fold) and Gli3 (>25-fold) 
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were upregulated in response to TGF-β.  However, Ptc1 expression was decreased by 40% 
under these conditions (43).  Given the marked upregulation of Gli3 and its known role as a 
transcriptional repressor, it is tempting to speculate that the differential response of Gli1 and 
Ptc1 promoters to TGF-β treatment may be attributed to Gli3 repression of Ptc1 expression.  
Yet each promoter contains a canonical Gli binding site, so it may be necessary to look 
beyond Gli-mediated mechanisms of regulation and conduct a more careful examination of 
the surrounding sequences in the promoter regions in a search for alternate transcription 
factor binding sites (44, 45) or regions of epigenetic regulation (46). 
 
Distribution of Shh in the adventitia 
Ptc1-lacZ and Ptc2-lacZ activities were colocalized with Shh protein that 
accumulates at the border between the media and adventitia.  Once secreted, movement of 
Hh proteins in the extracellular space is limited and regulated by multiple mechanisms which 
contribute to the formation of a prototypical morphogen gradient (47).  Covalent lipid 
modifications at both amino and carboxyl-terminal domains are required for the aggregation 
of Hh proteins into multimers, and thus for proper gradient formation and long-range 
signaling (48-53).  Secreted Hh protein multimers interact with heparan sulfate 
proteoglycans (HSPGs), which further regulates their movement (54, 55).  Chan et al. used 
mice carrying a mutation in the N-terminal Cardin-Weintraub motif of Shh to specifically 
investigate the requirement for Shh-proteoglycan interaction during development.  
Interestingly, disruption of Shh-proteoglycan interactions affected growth regulation in 
multiple organs but not tissue patterning.  Neural progenitor proliferation in the developing 
cerebellum, spinal cord, subventricular zone, and subgranular layer of the hippocampus was 
significantly impaired in mutant mice.  The authors further concluded that Shh-proteoglycan 
interactions are important both in delineating the progenitor cell niche and in modifying the 
response of individual cells to Shh ligand (56).  Finally, there are multiple mammalian 
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receptors that can bind Hh ligands at the cell surface, thus limiting ligand diffusion.  The 
expression of several of these receptors is regulated by Hh signaling, thus comprising a 
feedback mechanism.  Ptc1 and Hhip both bind and sequester Hh ligand at the cell surface, 
which causes a reduction in Hh ligand sensitivity of the individual Ptc1- and Hhip-expressing 
cell as well as reducing the availability of free ligand to neighboring cells.  Mice lacking Ptc1 
and Hhip exhibited multiple defects that were consistent with an increased magnitude and 
range of Shh signaling (57).   
Our data show that Shh protein is concentrated between the media and adventitia, 
outside the external elastic lamina.  The sequestration of high protein levels in this region 
may result from local synthesis, secretion, and retention of Shh multimers by ECM 
components, such as the HSPG perlecan (58), in the artery wall.  Ptc-lacZ-positive cells are 
located throughout the adventitia, whether directly adjacent to Shh protein at the media-
adventitia interface or several cell layers removed.  This suggests that Shh ligand is 
available throughout the adventitia, although it would be reasonable to expect a 
concentration gradient extending from the high protein levels found at the media-adventitia 
boundary.  The immunofluorescence staining methods that we use to visualize Shh protein 
localization may limit our ability to detect a subtle gradient in the artery wall.  Other data from 
our lab (not shown) suggests that multiple cell types throughout the adventitia both produce 
and respond to Shh ligand.  Therefore, it will be interesting to examine the specific 
localization of ECM components within the adventitia to determine if Hh-binding components 
such as HSPGs are preferentially concentrated near the media-adventitia border.   
 
Role of Shh signaling in establishing AdvSca1 niche 
The presence of residual AdvSca1 cells suggests that factors other than Shh are 
involved in homing and/or maintenance of these cells.  Because Dhh expression was 
detected in the aorta, low levels of Dhh may allow some of these cells to escape a 
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requirement for Shh in the artery wall.  As expected, we have found in preliminary 
experiments (not shown) that multiple other growth factor ligands, receptors, and pathway 
components are expressed in the adventitia.  One or more of these pathways may also 
partially compensate for the loss of Shh and permit some AdvSca1 cells to reside within the 
adventitia.   
Shh-deficient embryos do not form a septation complex in the truncus arteriosus 
(38).  We cannot at this time distinguish between direct effects caused by the loss of Shh 
signaling in AdvSca1 cells themselves versus indirect effects of Shh deficiency on the 
developing outflow arteries as the cause of the loss of AdvSca1 cells from the adventitia 
surrounding the vessels shown in Figure 11.  The lack of truncus arteriosus septation in 
Shh-/- outflow tracts is a result of defective migration of cardiac neural crest cells during 
early stages of cardiovascular development (38).  Lineage tracing experiments (see Chapter 
3) indicate that AdvSca1 cells are not themselves derived from neural crest.  However, this 
does not rule out the possibility that neural crest-derived cells secrete factors or ECM that is 
critical for the establishment of a functional adventitial niche.   
Hedgehog signaling has been shown to function cell-autonomously to regulate 
multiple aspects of progenitor cell behavior.  Progenitor cells in the adult liver can be 
identified by Ptc1 expression.  When these cells are isolated and cultured, treatment with 
cyclopamine, which blocks Hh signaling, induces apoptosis (59).  There have also been 
reports linking hedgehog signaling to progenitor cell maintenance in the hippocampus and 
subventricular zone of the brain (60) and to progenitor cell proliferation in the gut (61), inner 
ear (62), and skin (31).  Our data now points to a role for Hh signaling in promoting the 
proliferation of AdvSca1 cells.  In contrast to the robust effects of Hh pathway inhibition, we 
found that addition of exogenous Shh protein to AdvSca1 cells in vitro did not affect their 
differentiation or proliferation (Figure 19).  This suggests that AdvSca1 cells in culture are 
exposed to adequate concentrations of Hh factors, either through self-production and 
 51 
secretion or as supplied by serum-containing medium.  Whether the effect of Hh pathway 
activity on AdvSca1 cell proliferation is cell-autonomous remains to be investigated and will 
likely require the development of genetic tools permitting in vivo cell-specific targeting of 
AdvSca1 cells (see Chapter 5).   
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 CHAPTER 3 
Adventitial Sca1+ cells are maintained in an undifferentiated phenotype in vivo
58 
Introduction 
In many adult tissues, stem or progenitor cells are maintained locally and can be 
stimulated to participate in physiological and pathological tissue regeneration and repair.  
Vascular progenitor cells (including endothelial cell (EC) and smooth muscle cell (SMC) 
progenitors) have been identified in a variety of locations throughout the body, including 
blood, bone marrow, and adipose tissue (1).   
Stem cell antigen 1 (Sca1) is a glycosyl-phosphatidylinositol-anchored cell surface 
protein that was originally identified as an antigen upregulated on activated lymphocytes.  
Sca1 expression is commonly used as a method to identify and enrich hematopoietic stem 
cells, although it is also expressed by a variety of stem, progenitor, and differentiated cell 
types (2).  Defects observed in Sca1-null mice (which are viable) indicate that the protein 
does have a functional role in some cell types, including hematopoietic cells (3), 
mesenchymal stem cells (4), and myoblasts (5, 6).   
A novel population of Sca1+ progenitor cells was identified within the aortic adventitia 
of adult ApoE-/- mice by Hu et al. in 2004.  The adventitial Sca1+ (AdvSca1) cells also 
expressed the stem cell markers c-kit and CD-34.  Interestingly, bone marrow transplant 
experiments showed that AdvSca1 cells were not bone marrow-derived.  Isolated AdvSca1 
cells responded to platelet-derived growth factor BB (PDGF-BB) treatment in vitro by 
differentiating to SMCs.  AdvSca1 cells that were transferred to the adventitial surface of an 
irradiated vein graft in vivo underwent SMC differentiation and contributed to neointima 
formation (7). 
 The process of smooth muscle differentiation has important implications in both 
developmental and disease processes.  The transcription of most smooth muscle marker 
genes is controlled by one or more CArG elements found within promoter and/or intronic 
sequences.  CArG elements are bound by dimers of the transcription factor serum response 
factor (SRF).  However, SRF is not intrinsically specific for SMC genes; it is widely 
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expressed and can also regulate cardiac and skeletal muscle genes, as well as growth 
responsive genes such as c-fos (8).  In order to achieve specificity and precise control of 
SMC gene transcription, additional mechanisms of regulation must be present.  Several SRF 
cofactors have been shown to modulate its transcriptional activity (see Chapter 1).  These 
co-activators and co-repressors can augment or inhibit SRF transcriptional activity through 
physical association, modulating SRF-CArG binding, or indirectly inhibiting SRF-dependent 
gene expression. 
 During development, the smooth muscle cells and pericytes that are recruited by 
developing vessels arise from diverse embryonic origins (9).  Studies in avian and mouse 
systems have shown that there are at least four distinct populations contributing medial 
SMCs to the aorta, including cells derived from secondary heart field (10, 11), cardiac neural 
crest (12, 13), somites (14-16), and a transient population of SMCs originating from 
splanchnic mesoderm (17).  Cells from the proepicardial, serosal, and pleural mesothelia 
contribute SMCs to coronary, mesenteric, and pulmonary vessels, respectively (18-20).  
Several studies have suggested that SMCs of different developmental origins may also 
exhibit functional disparities.  For example, avian neural crest-derived SMCs responded very 
differently to TGF-β1 treatment in vitro than did mesoderm-derived SMCs (21).   
For years, investigations into the origin of SMCs in vascular disease were based on 
the idea that new SMCs arise from preexisting SMCs via dedifferentiation (22).  There have 
been multiple recent reports, however, that suggest new SMCs can also arise from adult 
progenitors which are found within the vessel wall itself (7, 23-27).  Resident progenitor cells 
within the arterial adventitia are perfectly poised to respond to local inductive signals and 
undergo smooth muscle differentiation to participate in vessel wall repair or disease 
processes.  Therefore, we have more closely examined the regulation of smooth muscle 
differentiation in AdvSca1 cells.   
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Hypothesis 
AdvSca1 cells in vivo express a “pre-SMC” phenotype that is poised for signal-
responsive SMC differentiation.  While normally maintained as progenitors within the vessel 
wall, AdvSca1 cells will respond to differentiation stimuli by upregulation of SMC marker 
genes and differentiation to a mural cell phenotype.   
 
Materials and Methods 
Animals Used:  All protocols were approved by the Institutional Animal Care and Use 
Committee at the University of North Carolina.  Mice used include Wnt1-cre (Tg(Wnt1-
cre)11Rth Tg(Wnt1-GAL4)11Rth/J; Jackson Laboratories; 003829), Nkx3.2-cre (gift of 
Warren Zimmer, Texas A&M University, described in (28)), WT1-cre (gift of John Burch, Fox 
Chase Cancer Center), Tie2-cre (Tek-cre1Ywa/J; Jackson Laboratories; 008863), Rosa26-
reporter (B6.129S4-Gt(ROSA)26Sortm1Sor/J; Jackson Laboratories; 003474), Ptc1-lacZ 
(Ptch1tm1Mps, Jackson Laboratories; 003081, described in (29)), Ptc2-lacZ (Ptc2tm1Dgen; 
Jackson Laboratories; 005827), Rosa26 (B6.129S7-Gt(ROSA)26Sor/J; Jackson 
Laboratories; 002192), SM22α-lacZ (gift of Li Li, Wayne State University, described in (30)), 
VE-cadherin-cre (B6.Cg-Tg(Cdh5-cre)7Mlia/J; Jackson Laboratories; 006137), tdTomato 
(B6.129(Cg)-Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J; Jackson Laboratories; 007676), and 
C57BL/6J (Jackson Laboratories).  Noon on the day of vaginal plug was designated E0.5. 
β-Galactosidase Assay:  Embryos or tissues were fixed in fresh 0.2% glutaraldehyde 
and stained with a solution containing 5 mM potassium ferricyanide, 5 mM potassium 
ferrocyanide, and 1 mg/ml X-gal substrate at 37°C overnight.  Postfixation was performed in 
4% paraformaldehyde (PFA) at 4°C overnight.  For histological analysis, tissue was 
dehydrated, cleared (Histo-Clear; National Diagnostics), embedded in paraffin, sectioned, 
and counterstained with nuclear fast red (Vector Laboratories). 
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Immunofluorescence Staining:  Tissues were fixed for 1 hr in freshly prepared 4% 
PFA, rinsed in PBS, saturated with 20% sucrose for cryoprotection, embedded in agar, and 
frozen in OCT.  Twelve-micrometer cryosections were fixed in methanol at room 
temperature for 5 min, permeabilized with 0.05% Tween-20 (in PBS) for 2 min, rinsed in 
PBS, then blocked in 2% normal goat serum (NGS) or normal donkey serum for 2–8 h.  
Sections were incubated with primary antibodies at 4°C overnight, rinsed twice in PBS + 
0.1% BSA, then incubated with secondary antibodies for 2-8 h at room temperature, 
protected from light.  Nuclei were counterstained with 10 μg/ml Hoechst 33258 in H2O and 
slides were mounted in Mowiol with 2.5% DABCO. 
For cells in culture, cells were fixed by incubating in freshly prepared 4% PFA for 15 
min at room temperature, then permeabilized with 1:1 methanol/acetone for 1 min.  Cells 
were blocked in 2% NGS for 1-4 h at 4°C, then incubated with primary antibodies at 4°C 
overnight.  After two rinses in PBS + 0.1% BSA, cells were incubated with secondary 
antibodies 1-4h at room temperature protected from light.  Nuclei were counterstained with 
10 μg/ml Hoescht 33258 in H20.  For BrdU dual-labeling experiments, cells were first 
incubated with other primary and secondary antibodies, then postfixed in 4% PFA for 15 min 
at room temperature.  To access BrdU antigen, DNA was denatured in 2M HCl for 5 min at 
room temperature.  Cells were rinsed twice with PBS to neutralize residual acid, and then 
stained according to standard protocol. 
Primary antibodies used for these studies included rabbit anti-β-galactosidase 
(1:500; MP Biomedical 55976), mouse anti-BrdU (1:400; BD Pharmingen 555627), rabbit 
anti-SM-MHC (1:100; Biomedical Technologies BT-562), mouse anti-SMαA (1:100; Sigma 
A2547), rat anti-Sca1 (1:100; BD Pharmingen 553333), rabbit anti-SRF (1:100; Santa Cruz 
Biotechnology sc335), and rat anti-PECAM-1 (1:100; BD Pharmingen 550274).  All 
secondary antibodies were AlexaFluor-conjugated (Invitrogen) and used at a dilution of 
1:400 in PBS.  Immunofluorescence staining was visualized with a Leica BM IRB inverted 
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epifluorescence microscope, with images captured by a QImaging Retiga 1300 digital 
camera.  Confocal images were obtained with a Zeiss LSM5 Pascal laser scanning confocal 
microscope and processed with Image J and Adobe Photoshop. 
AdvSca1 Cell Isolation and Culture:  Mice were sacrificed by cervical dislocation and 
perfused through the left ventricle with PBS.  The thoracic aorta was cut at the diaphragm 
and periadventitial fat was cleared from around the vessel.  The aorta was gently lifted away 
from the dorsal body wall, with intercostal arteries trimmed even with aortic wall.  In arch 
region, the superior vena cava and pulmonary artery were cleared and branching arteries 
and ductus arteriosus were trimmed even with the aortic wall.  At the junction with the 
myocardium, the aorta was cut flush with the ventricular wall and placed in HBSS at 37ºC.  
Before digesting, any remaining fat and coagulated blood were cleared from the tissue. 
Whole aortas were briefly digested in 0.4 mg/mL collagenase in HBSS at 37°C for 6 
min.  Tissue was immediately removed and placed in fresh HBSS at 37°C.  Adventitia was 
gently separated from the media of each aorta by peeling the layer up and over the vessel.  
Adventitias were placed in the second digestion solution of 15 mg/mL collagenase II 
(Worthington, 4176) and cut into small pieces.  Tissue was digested for 2-2.5 hrs at 37°C 
with constant rocking to achieve a single-cell suspension, which was then passed through a 
30 μm pre-separation filter (Miltenyi, 130-041-407).  Filtrate was collected and cells were 
pelleted at 300xg then rinsed in PBS + 0.5% BSA.  Aortic Sca1+ cells were isolated using 
anti-Sca1 immunomagnetic MicroBeads (Miltenyi ) and a MACS cell separation system 
(Miltenyi ) according to manufacturer’s instructions.  Cells were passed over two consecutive 
columns to increase purity of the isolation.  Isolated Sca1+ cells were cultured in DMEM 
(Sigma) plus 10% FBS (HyClone) and 1x antibiotic/antimycotic solution (Gibco) at 37°C, 5% 
CO2.  Cells were seeded in 48-well tissue culture plates at a density of 8x103-1.5x104 cells 
per well, depending on the assay.  
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Growth factor treatments and induction of adipocyte differentiation:  In some 
experiments, isolated AdvSca1 cells were treated with growth factors, including recombinant 
human BMP2 (PeproTech, 120-02); recombinant human PDGF-BB (R&D Systems, 220-
BB); recombinant mouse Sonic hedgehog (C25II) N-terminus (R&D Systems, 464-SH); 
recombinant human TGF-β1 (R&D Systems, 240-B); and recombinant human FGF-basic 
(Peprotech, 100-18B). 
For adipocyte differentiation, AdvSca1 cells were grown to confluency under 
standard conditions.  Cells were then treated with MDI induction medium (11.5 μg/mL 
isobutylmethylxanthine (Sigma, I7018); 1 μg/mL insulin (Sigma, I5500); 1 μM 
dexamethasone (Sigma, D4902) in DMEM + 10% FBS) for two days followed by treatment 
with 1 μg/mL insulin in DMEM + 10% FBS for two days.  Cells were then incubated under 
standard conditions for an additional four days before Oil Red O staining. 
RT-PCR Analysis:  Total cellular RNA was isolated by guanidinium isothiocyanate 
denaturation and phenol/chloroform extraction as described (31). Two-step RT-PCR was 
carried out with the GeneAmp RNA PCR kit (Applied Biosystems) according to the 
manufacturer’s instructions.  The sequences for primers used for RT-PCR analysis of gene 
expression are provided in Appendix B.  Unless otherwise indicated, primer sequences were 
designed for this study based on mouse genomic sequence available through Ensembl 
(release 45, June 2007; (32)). Primers were designed with the aid of Primer3 software (v. 
0.4.0) (33).   
Cell Proliferation and Differentiation Assays:  For experiments to determine whether 
AdvSca1 cells can express SMC differentiation markers in the absence of cell proliferation, 
AdvSca1 cells were isolated by immunoselection with magnetic microbeads and a MACS 
cell separation system (Miltenyi Biotech) and cultured for 5 days in DMEM + 10% FBS + 1x 
antibiotic/antimycotic (Sigma) to allow cells to attach and spread on the culture substrate.  At 
5 days, cell proliferation was arrested by the addition of 50 μM aphidicolin (in DMSO; Sigma 
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A0781) or 8 mM hydroxyurea (in H2O; Sigma, H8627) and cells were cultured for an 
additional 10 days. To verify growth arrest, 25 μM BrdU (BD Pharmingen 550891) was 
added to each well with or without inhibitors. 
Histological Staining:  Alizarin red S and von Kossa staining procedures were similar 
to those described (34).  For alizarin red staining, cultures were washed three times in 
150mM NaCl, then fixed in ice-cold 70% ethanol for 1 h. Cells were rinsed with ddH20, 
incubated with alizarin red staining solution (2% alizarin red in H2O, pH 4.3) at room 
temperature for 10 min, then washed five times in ddH2O and photographed.  For von Kossa 
staining, cultures were rinsed twice in ddH2O then incubated in 1% (wt/vol) silver nitrate 
under UV illumination for 45 min.  After two rinses in ddH2O, cells were treated with 3% 
(wt/vol) sodium thiosulfate to remove unreacted silver.  Cells were then rinsed once in 
ddH2O, counterstained in van Gieson solution (0.6% picric acid, 0.0375% acid fuchsin in 
H20) for 5 min, then washed in 70% ethanol, dried, and photographed.   
For Oil Red O staining of lipids, medium was removed from cultured cells and cells 
were fixed in 10% formalin in PBS for 5 min at room temperature.  The solution was 
changed to fresh 10% formalin, and cells were incubated 1 hr.  Formalin was removed, and 
wells were rinsed with ddH2O.  All liquid was removed from wells, and cells were incubated 
in 3.5 mg/mL Oil Red O (Sigma, O0625) in isopropanol for 10 min.  After removing Oil Red 
O solution, cells were immediately rinsed 5x in ddH2O and photographed. 
Matrigel plug assay:  AdvSca1 cells were isolated according to standard procedure 
and counted.  Aliquots of 1.5x105-2x105 cells were resuspended in ice-cold Matrigel (growth-
factor-reduced, phenol red-free; BD Biosciences, 356231) with or without growth factors, as 
indicated in text.  Matrigel solution was drawn into a pre-chilled 1 mL syringe fitted with a 23-
gauge needle and kept on ice.  Under isoflurane anesthesia, female C57BL/6J mice, aged 
8-16 weeks, were shaved in two patches on the upper dorsal area, just lateral to the midline.  
Matrigel was injected subcutaneously on either side of the midline, and mouse was revived.  
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At the indicated timepoints, host mice were sacrificed, and the Matrigel plugs were carefully 
dissected from the subcutaneous connective tissue.  Depending on the experiment, plugs 
were processed for X-gal staining according to standard protocol or fixed for one hour in 
fresh 4% PFA and then processed for cryo-embedding according to standard protocol.   
Carotid ligation surgery:  Blood flow reduction in the left common carotid artery  was 
performed as previously described (35, 36).  Briefly, Ptc2-lacZ mice aged 3-4 months were 
anesthetized with isoflurane and maintained at 37°C on a heating pad.  Using sterile 
technique, connective tissue was gently separated to expose ~0.5-mm lengths of the left 
external carotid artery distal to the thyroid artery and the left internal carotid/occipital artery 
pair.  The internal and external carotid arteries were ligated with 6-0 silk suture and the area 
was rinsed with anti-bacterial 0.9% saline solution before closure.  Sham operations 
followed the same procedure, but artery ligation was omitted.  Mice received antibiotic (50 
mg/kg cephazolin) and analgesic (10 mg/kg im Pentazocine) and were monitored for one 
week post-surgery.   
 
Results 
Developmental origins of AdvSca1 cells 
 Following multiple lineage tracing studies in both avian and mouse systems, the 
developmental origins of smooth muscle cells can be plotted on a lineage map with some 
confidence (Figure 15A, reviewed in (9)).  In contrast, however, very little is known about the 
embryonic origins of adventitial cells, including adventitial Sca1+ progenitor cells (AdvSca1 
cells).  Hu et al. performed bone marrow reconstitution experiments in which an irradiated 
adult mouse received a transplant of isolated AdvSca1 that were genetically marked by 
constitutive β-galactosidase expression.  After six months, no Sca1+β-gal+ cells were 
identified in the adventitia, indicating that AdvSca1 cells were not renewed by marrow-
derived cells within this time period (7).   
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Based on the proximity of AdvSca1 cells to underlying medial SMCs, we 
hypothesized that AdvSca1 cells may derive from the same embryonic origin.  Cells of 
neural crest origin are responsible for establishing the septation between the aorta and 
pulmonary trunk during midgestation (12) and populate portions of the pulmonary trunk and 
ascending and transverse aorta.  We used Wnt1-cre transgenic mice (13) to label cells of 
neural crest origin.  Wnt1-cre-activated β-gal reporter (R26R) labeled neural crest-derived 
SMCs in proximal aorta, pulmonary trunk, common carotid arteries, and ductus arteriosus, 
but did not label the adventitial layer or AdvSca1 cells in these vessels (Figure 14B-C, 
Figure 15).  Distal to the segment of aortic media labeled by Wnt1-cre, SMCs of sclerotome 
origin are β-gal+ in Nkx3.2-cre/R26R mice (37) (Figure 14D).  Somite-derived SMCs are also 
found in the outer layers of the aortic media and within the pulmonary trunk at the level of 
the aortic root, but adventitial cells are β-gal- (Figure 14E).  Wilms tumor 1 (WT1) is a 
marker of mesothelial cells (38) and Tie2 (TEK) is expressed by endothelial cells and 
hematopoietic stem cells (39).  Both populations represent reasonable sources of AdvSca1 
cells, yet neither WT1-cre/R26R nor Tie2-cre/R26R mice display significant adventitial 
staining in areas where AdvSca1 cells are known to be abundant (Figure 14F-G).  Tie2-cre 
does label scattered SMCs in the pulmonary trunk and occasional adventitial cells (Figure 
14G).  However, regions known to harbor abundant AdvSca1 cells at this stage, such as the 
adventitia between the aorta and pulmonary trunk, are negative for Tie2-cre-labeled cells.  
Thus, the developmental origins of AdvSca1 cells differ from their neighboring SMCs and 
are as of yet unknown.   
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Figure 14.  Lineage tracing of arterial cells.  (A) Schematic of known embryonic origins for 
vascular smooth muscle cells, adapted from Majesky, 2007 (9).  In the aortic region where 
AdvSca1 cells are abundant, adjacent SMCs are derived from cardiac neural crest (CNC), 
anterior heart field, somites, and proepicardium.  (B,D,F)  Whole-mount images of mice 
carrying cre under the (B) Wnt1, (D) Nkx3.2, or (F) Wilms tumor-1 (WT1) promoters.  When 
crossed with Rosa26-reporters (R26R), cells of the (B) cardiac neural crest, (D) sclerotome, 
or (F) proepicardial lineages are identified by expression of β-galactosidase, as revealed by 
X-gal staining (blue cells).  (C,E,G) Cross-sections of X-gal stained tissue from the aortic 
root region, counterstained with nuclear fast red.  (B-C) In proximal aorta and pulmonary 
trunk, subsets of SMCs are derived from CNC.  SMCs in the aortic root region are β-
galactosidase-positive (blue) while adventitial cells are negative (C).  (D-E) Labeling of cells 
derived from the Nkx3.2-expressing splanchnic mesoderm lineage.  Note that positive cells 
are found primarily in the outer layers of medial smooth muscle in the aorta, complementary 
to the pattern of CNC-derived SMCs (compare C and E).  However, the majority of 
adventitial cells in the aortic root region are still negative.  (F) A scattering of SMCs (but not 
adventitial cells, data not shown) in the proximal aortic root are derived from a WT1-cre-
expressing lineage.  (G) Tie2-cre labels endothelial and hematopoietic cells.  Note: the large 
β-galactosidase+ clusters on the outside of the pulmonary trunk are areas of coagulated 
blood that persisted through dissection and tissue preparation.  While some adventitial cells 
appear positive, the region between the aorta and pulmonary trunk where AdvSca1 cells are 
particularly abundant is negative, indicating that most, if not all, AdvSca1 cells originate from 
a different source during development.  Ao, aorta; PT, pulmonary trunk; d.Ao, descending 
aorta. 
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Figure 15.  Analysis of β-galactosidase and Sca1 expression in Wnt1-cre/R26R vessels.  
(A) Cross-section of X-gal-stained aortic root from a Wnt1-cre/R26R mouse at 4 wks.  
Dashed box indicated general region shown in B-D.  (B-D) Cryosections of Wnt1-cre/R26R 
vessels, with aorta to the top/left and pulmonary trunk to the bottom/right.  
Immunofluorescence staining is as indicated.  Note the lack of overlap between β-
galactosidase and Sca1 (C), confirming that AdvSca1 cells in this region are not derived 
from cardiac neural crest.  Ao, aorta; PT, pulmonary trunk. 
 
 
 
Analysis of isolated AdvSca1 cells 
 To characterize the properties of AdvSca1 progenitor cells, we used 
immunomagnetic beads to isolate Sca1+ cells from aortic adventitial tissue (see Materials 
and Methods).  AdvSca1 cells in vivo do not express markers of a differentiated phenotype 
(Figure 16A).  However, when isolated cells were cultured in DMEM containing 10% serum, 
many AdvSca1 cells (~30–50%) lost expression of Sca1, gained expression of SMα-actin, 
SM22α, calponin, and SM-MHC, and adopted an elongated, mesenchymal cell shape 
(Figure 16B).  
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Figure 16.  Differentiation of AdvSca1 cells in vitro.  (A) In a cross-section through the adult 
aorta, Sca1+ cells (red) are evident in the adventitia, distinct from SMα-actin-expressing cells 
(green) of the media.  (B) After 8 days in culture, a subset of AdvSca1 cells has lost Sca1 
expression and upregulated SMα-actin.  When removed from the adventitia and cultured, 
AdvSca1 cells upregulate SMC markers without additional exogenous treatment.  M, media; 
A, adventitia. 
 
 
 To rule out the possibility that up-regulation of SMC markers resulted from expansion 
of a pool of medial SMCs carried over in the AdvSca1 cell isolation, we repeated our 
experiments in the presence of aphidicolin or hydroxyurea, inhibitors of cell proliferation.  
After verifying growth arrest, we observed up-regulation of SMC marker proteins over a 
similar time course and to a similar extent as seen in the absence of cell cycle inhibitors 
(Figure 17).  We conclude that AdvSca1 cells can directly differentiate into SMC-like cells, 
and that this differentiation does not require cell proliferation. 
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Figure 17.  AdvSca1 cell differentiation in the absence of cell division.  (A-C) Isolated 
AdvSca1 cells were cultured in serum-containing medium in the presence of 10μM BrdU.  
Proliferating cells are identified by BrdU immunostaining (red nuclei).  The addition of 50μM 
aphidicolin (B) or 8 mM hydroxyurea (C) strongly inhibited cell proliferation, as indicated by 
the absence of BrdU staining.  The up-regulation of SMα-actin (green) in AdvSca1 cells 
does not require cell proliferation. 
 
We tested the response of isolated AdvSca1 cells to treatment with factors 
commonly associated with the modulation of smooth muscle differentiation, including 
transforming growth factor β1 (TGF-β) and platelet-derived growth factor BB (PDGF-BB).  In 
contrast to results from Hu et al, we did not observe a significant response of AdvSca1 cells 
to PDGF-BB treatment, as assessed by immunostaining for Sca1 and SMα-actin or by semi-
quantitative RT-PCR (Figure 18B,E).  Following TGF-β treatment, we consistently observed 
a dramatic downregulation of Sca1 expression, indicating that AdvSca1 cells are TGF-β-
responsive.  Since AdvSca1 cells reside within a Shh-responsive environment in the 
adventitia and are at least partially dependent on Shh signaling for proper development (see 
Chapter 2), we also tested for an in vitro response to exogenous Shh ligand.  No changes in 
Sca1 or SMα-actin expression were induced by Shh treatment (Figure 18C and data not 
shown).  These results suggest that Shh signaling may not be critical for regulating AdvSca1 
differentiation, but do not rule out other roles, such as regulation of proliferation (see 
Chapter 2).   
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Figure 18.  AdvSca1 cell response to growth factor treatments in vitro.  (A-D) Isolated 
AdvSca1 cells were cultured for 6 days to allow attachment, then treated with (A) no 
additional factors, (B) 10 ng/mL PDGF-BB, (C) 1 μg/mL Shh(C25Il)-N, or (D) 5 ng/mL TGF-β 
for an additional 8 days.  Cells were fixed and stained for SMα-actin and Sca1.  (E)  In a 
separate experiment, isolated AdvSca1 cells were cultured for 6 days to allow attachment 
and then treated with TGF-β (0, 5, or 20 ng/mL) or PDGF-BB (0, 10, or 50 ng/mL) for 48 hrs.  
RNA was collected, and the expression of SMα-actin and Sca1 was evaluated by RT-PCR.  
β-actin was used as a loading control.  Treatment of established AdvSca1 cultures with 
TGF-β induces downregulation of Sca1, but PDGF-BB does not provoke a robust response.  
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Multipotent adult mesenchymal stem cells have been characterized by several 
criteria, including the capacity to differentiate to bone, cartilage, and adipose tissue (40).  
Having established the inclination of AdvSca1 cells to differentiate to SMC-like cells when 
placed in culture, we sought to test whether AdvSca1 cells also harbored the potential for 
other mesenchymal cell types.  When isolated AdvSca1 cells were incubated with BMP2 (50 
ng/ml, 20 days), colonies formed that stained with alizarin red or von Kossa’s stain (~1
 
 
Figure 19.  Other possible mesenchymal fates of AdvSca1 cells in vitro.  Isolated AdvSca1 
cells were cultured in medium without (A-C) or with the addition of BMP2 (50 ng/ml, 20 days) 
(D-E) or adipogenic induction factors (8 days total, see Materials and Methods) (F).  (A,D) 
Alizarin red forms a red-orange complex with calcium ions indicating the formation of 
calcified nodules (black arrows in D).  (B,E) Von Kossa staining indicates the presence of 
mineralized colonies by the formation of silver salts, which are reduced to black metallic 
silver (green arrows in E).  (C,F) Oil Red O stains lipid droplets produced by adipogenic cells 
(blue arrows in F).  The overall frequencies of AdvSca1 differentiation to either osteogenic or 
adipogenic fates upon appropriate treatment were at least 10-fold lower than that observed 
for differentiation to SMα-actin-positive cells in standard AdvSca1 cultures. 
 
 
colony per 400 cells plated), consistent with differentiation of a subset of AdvSca1 cells to 
osteogenic cells (Figure 19D-E).  Under conditions commonly used to promote adipogenic 
differentiation (see Materials and Methods), oil red O staining revealed lipid-rich clusters in 
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AdvSca1 cultures (~1 colony per 700 cells plated, Figure 19F).  AdvSca1 cells as a 
population are thus multipotent and have the capacity to differentiate to other mesenchymal 
cell types, although at a much lower frequency than that observed for SMC differentiation. 
 
AdvSca1 cells regulate the expression of smooth muscle genes 
 AdvSca1 cells do not express SMC marker proteins in vivo (Figures 9 and 16).  
However, they contain mRNAs for transcription factors involved in SMC differentiation, 
 
 
 
Figure 20.  Analysis of AdvSca1 gene regulation during in vitro differentiation. (A) Freshly 
isolated AdvSca1 cells (red) contain SRF (green) colocalized with DAPI-stained nuclei (blue) 
(arrows).  (B) Freshly isolated AdvSca1 cells (red) contain Klf4 (green) colocalized with 
DAPI-stained nuclei (blue) (arrows).  (C) RT-PCR analysis of AdvSca1 cells cultured for 0, 
12, or 28 days.  M is total RNA from aortic media used as a positive control for SMC 
markers.  This analysis was performed three times with similar results.  (D) AdvSca1 cells 
cultured in serum-containing medium for 9 days. Many cells down-regulate ScaI (red) and 
up-regulate SM α-actin (green).  As AdvSca1 cells differentiate in vitro, repressors of SMC 
gene expression are downregulated and activators become more highly expressed. 
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including serum response factor (SRF), myocardin family members, and cysteine-rich LIM 
proteins Csrp1 and Csrp2 (Figure 20C).  In addition, a subset of freshly isolated AdvSca1 
cell nuclei were immunopositive for SRF protein (Figure 20A).  However, AdvSca1 cells also 
express potent silencers of SRF-dependent transcription, including Msx1, Klf4, and FoxO4 
(Figure 20C and data not shown).  Each of these factors can inhibit SRF and myocardin-
dependent SMC gene expression (41-43), and they are down-regulated as AdvSca1 cells 
acquire SMC markers and increase SRF co-activator expression (Figure 20C).  Therefore, a 
subset of AdvSca1 cells may be maintained as SMC progenitors by expression of silencers 
of SRF-dependent transcription. 
 
Cells derived from AdvSca1 progenitors contribute to vascular structures in Matrigel 
plugs 
 Our results indicate that a subset of AdvSca1 cells readily differentiates to SMCs and 
SMC-like cells in vitro.  To evaluate the behavior of isolated AdvSca1 cells in vivo, we 
suspended the cells in Matrigel containing basic fibroblast growth factor (FGF2) and 
implanted them subcutaneously into a host mouse.  The combination of Matrigel and FGF2 
is known to promote neovascularization within the plug (44).  We found that the presence of 
AdvSca1 cells in the Matrigel plugs promoted a greater degree of organized vascularization 
compared to plugs without cells added (Figure 21, compare A and B).  Using AdvSca1 cells 
isolated from mice that constitutively express β-galactosidase from the Rosa26 promoter 
reveals that AdvSca1-derived cells integrate into the microvascular network (Figure 21C,D).  
Cross-sections did not offer enough resolution to differentiate between AdvSca1-derived 
endothelial cells and mural cells (Figure 21D), so we took advantage of genetically modified 
mice to label endothelial cells and SMC-like cells.   
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Figure 21.  Participation of AdvSca1cells in Matrigel plug angiogenesis.  (A-B) Hematoxylin 
and eosin staining of 12-day Matrigel plugs with 0.5 µg/mL human FGF2 containing no 
added cells (A) or freshly isolated AdvSca1 cells (B).  The presence of AdvSca1 cells 
promotes the organization and assembly of cells within the Matrigel plug into vascular 
structures.  (C-D) 10-day Matrigel plug with AdvSca1 cells from Rosa26 mice (constitutive 
expression of β-galactosidase in all tissues) and 0.2 µg/mL human FGF2.  (C) X-gal staining 
permits visualization of an organized vascular network in a whole-mount view.  (D) A cross-
section through the plug reveals β-gal+ cells associated with functional, lumenized 
microvessels.  The presence of red blood cells (arrowhead) indicates connection with the 
host systemic circulation.  (E) AdvSca1 cells were isolated from SM22-lacZ mice and 
incubated in a Matrigel plug with 0.5 µg/mL human FGF2 and 60 U/mL heparin for 14 days.  
Scattered β-gal+ cells indicate that a subset of AdvSca1 cells differentiate to SM22+ mural 
cells.  (F)  AdvSca1 cells were isolated from VE-cadherin-cre/R26R mice and incubated in a 
Matrigel plug with 0.5 µg/mL human FGF2 and 60 U/mL heparin for 10 days.  β-gal+ cells 
within the newly formed microvessels indicate that a subset of AdvSca1 cells differentiate to 
endothelial cells. 
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LacZ expression in SM22α-lacZ transgenic mice recapitulates the arterial smooth 
muscle expression pattern of SM22α transcripts but does not label visceral and venous 
SMCs during development (30).   From previous reports, it appears that the pattern of 
SM22α expression in pericytes varies according to developmental stage and anatomic 
location, with evidence that capillary pericytes at E10.5 do not express SM22α (45) while 
postnatal retinal capillaries are SM22α-positive (46).  When AdvSca1 cells from SM22α-lacZ 
mice (30) were implanted in Matrigel plugs, we observed scattered β-gal+ cells associated 
with vascular structures after 14 days of incubation (Figure 21E).  These results suggest that 
AdvSca1 cells have the potential to undergo differentiation to SMC-like cells in vivo and 
reside in a perivascular location.  The VE-cadherin-cre transgene targets cre recombinase 
expression to vascular endothelium, including quiescent adult vasculature (47).  In Matrigel 
plugs containing AdvSca1 cells isolated from VE-cadherin-cre/R26R mice, we observe lacZ+ 
cells within the newly formed microvascular network (Figure 21F), indicating that AdvSca1 
cells also have endothelial differentiation potential.   
In order to expand our analysis of AdvSca1 in vivo differentiation potential, we 
isolated cells from mice expressing a membrane-targeted tdTomato fluorescent protein 
constitutively expressed in all tissues (48).  Analysis of Matrigel plugs by confocal 
microscopy reveals AdvSca1-derived cells contributing to extensive vascular networks after 
14 days of incubation (Figure 22A).  Importantly, vessels surrounded by tdTomato-positive 
cells contained Ter119-positive erythroid cells inside the lumen, with no apparent leaking of 
red blood cells into the perivascular space (Figure 22B), suggesting the tdTomato-positive 
cells contribute to vascular wall stability and maturation.  Immunostaining of cross-sections 
through the Matrigel plugs showed co-labeling of tdTomato-positive cells with several 
pericyte markers, including SMα-actin, PDGFR-β, and chondroitin sulfate proteoglycan 4 
(Cspg4 or NG2) (Figure 23).  Together with the perivascular localization of tdTomato- 
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Figure 22.  Analysis of a Matrigel plug vascular network derived from AdvSca1 cells.  
Freshly isolated AdvSca1 cells from tdTomato mice were incubated with 0.5 µg/mL human 
FGF2 and 60 U/mL heparin.  (A) At 14 days an extensive network is evident.  Vessels are 
functional by 10 days (B) with TER119-positive red blood cells found within the lumens.  
AdvSca1 cells contribute to an extensive, functional vascular network in Matrigel plugs. 
 
 
 
positive cells, these results demonstrate that AdvSca1 cells have the potential to 
differentiate to functional mural cells in Matrigel plugs in vivo. 
Based on the mural cell differentiation of AdvSca1 cells in vivo, we checked for 
expression of common pericyte markers.  Freshly isolated AdvSca1 cells express RGS5, 
Cspg4 (NG2), and PDGFR-β but not desmin (Figure 24A).  Moreover, when cultured 
AdvSca1 cells were treated with 50 ng/mL PDGF-BB for 24 hrs, they adopted an elongated 
morphology reminiscent of cultured tumor-derived perivascular progenitor cells as reported 
by Song et al. (49).  Together, these results suggest that AdvSca1 cells share some 
features of pericytes, including responsiveness to PDGF-BB signaling, and can differentiate 
to perivascular mural cells in vivo.   
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Figure 23.  Expression of pericyte markers in perivascular mural cells derived from AdvSca1 
cells.  Isolated AdvSca1 cells expressing membrane-localized tdTomato fluorescent protein 
were incubated in Matrigel plugs with 0.5 µg/mL human FGF2 and 60 U/mL heparin for 10 d.  
Single confocal Z-sections indicate tdTomato co-localization with SMα-actin (arrowheads, 
A), PDGFR-β (arrowheads, B), and NG2 (arrowheads, C).  PECAM staining (A,C) marks 
endothelial cells.  AdvSca1 cells in Matrigel plugs differentiate to mural cells and express 
pericyte markers.   
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Figure 24.  Pericyte marker RT-PCR and PDGF treatment of AdvSca1 cells in vitro.  (A) 
RNA from freshly isolated AdvSca1 cells was screened for expression of common pericyte 
markers by RT-PCR.  (B-C) Treatment of AdvSca1 cells in vitro with 50 ng/mL PDGF-BB for 
24 hr induces morphology changes (C) compared to untreated cells (B).  AdvSca1 cells 
share some markers with pericytes and readily adopt an elongated morphology in response 
to PDGF-BB stimulation. 
 
AdvSca1 behavior during flow-induced neoadventitia formation 
In the mouse model of flow-induced carotid artery remodeling described by 
Korshunov and Berk, the left internal and external carotid arteries are ligated, thus restricting 
blood flow to the occipital artery (Figure 25A).  Immediately after ligation, blood flow is 
reduced by ~90% in the left common carotid artery (LCA) and increased by ~70% in the 
right carotid artery (RCA).  Over the course of 4 weeks following ligation, the LCA exhibits a 
characteristic sequence of vascular remodeling events, culminating in significant neointima 
formation and decrease in lumen volume (35).   
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One of the earliest responses to flow reduction is significant adventitial thickening, 
which can be observed by one week post-ligation.  Indeed, adventitial proliferation is an 
early response to several forms of vascular injury, as discussed in Chapter 1.  However, to 
our knowledge, no study has investigated which cell types within the adventitia exhibit this 
early proliferative response.  Thus, we examined Sca1 expression in the adventitia of carotid 
arteries at one and two weeks post-ligation.  In the ligated group, the left internal and 
external carotid arteries of 4 month-old Ptc2-lacZ mice were ligated as described (36) 
(Figure 25A).  In sham controls, the surrounding tissue was gently separated to expose the 
vessel, but no ligature was placed.   
In order to determine whether hedgehog signaling is altered during neoadventitia 
formation, we stained segments of the common carotid arteries with X-gal.  At one week 
post-ligation, the time at which the greatest adventitial response had previously been 
observed (35), the number of lacZ-positive cells appears grossly unchanged when ligated 
LCAs are compared to either sham controls or contralateral RCAs (Figure 25B).  Similar 
results were observed at two weeks post-ligation.   
Upon examination of carotid artery cross-sections, we observe an increase in 
adventitial area and the number of AdvSca1 cells in ligated vessels at one week post-
ligation (Figure 25C).  However, by two weeks post-ligation there is no observable difference 
between ligated vessels and sham controls, suggesting that the adventitial response to flow 
reduction occurs early in the remodeling process, well before neointimal development at 2-4 
weeks post-ligation.  The increase in AdvSca1 cells in response to flow-reduction could 
result from the proliferation of resident cells or the recruitment of circulating Sca1+ cells.  To 
begin to address this question, we stained one-week cross-sections with the mitotic marker 
phospho-histone H3.  Mitotic AdvSca1 cells, while not abundant, are present in the 
adventitia at one week post-ligation (Figure 26).  These results suggest that the expansion
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Figure 25.  Adventitial response to carotid flow-reduction.  (A) Schematic showing 
placement of ligations of left internal and external carotid arteries, just distal to the vessel 
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bifurcation.  Adapted from Korshunov and Berk, 2003 (35).  (B) Adult Ptc2-lacZ mice were 
used for surgery.  Vessels were isolated at one or two weeks post-ligation, and segments of 
the common carotid artery were stained with X-gal to reveal hedgehog-responsive cells.  (C) 
Sections of the common carotid artery stained with SM α-actin (green), Sca1 (red), and 
DAPI. 
 
 
of AdvSca1 cells results from proliferation of cells already present, as opposed to 
recruitment of new cells from distal sites.  Additional experiments at earlier timepoints will be 
necessary to thoroughly address both the regulation of Hh signaling during neoadventitial 
formation and the proliferation of resident AdvSca1 cells (see Future Directions).   
 
 
 
Figure 26.  AdvSca1 cells proliferate in response to flow-reduction.  (A) Cross-section of 
ligated LCA at one week post-ligation, stained for phospho-histone H3 (green), Sca1 (red), 
and DAPI (blue).  Elastin layers in the media are visible by green autofluorescence.  (B) 
Higher magnification confocal image of mitotic (pH3-positive) AdvSca1 cells.   
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Discussion 
Development of the adventitia 
The origins of AdvSca1 cells are unclear.  We investigated this question for aortic 
AdvSca1 cells by using genetically modified mice to mark cells of lineages known to 
contribute to local SMC populations.  Crossing Wnt1-cre transgenic mice to Rosa26-reporter 
mice generates offspring in which β-gal is permanently expressed in neural crest-derived 
cells (13).  Migrating neural crest cells are responsible for aorticopulmonary septation (12), 
which occurs at ~E10.5 during mouse development (50).  The neural crest population is 
known to contribute SMCs to the aortic root, a region with numerous AdvSca1 cells in the 
adventitia.  However, our results show that AdvSca1 cells directly adjacent to Wnt1-cre-
positive aortic SMCs did not express the neural crest marker when evaluated by either lacZ 
histochemical staining or by anti-β-galactosidase immunostaining (Figure 15C).  Moreover, 
our developmental time course studies indicate that AdvSca1 cells do not appear in aortic 
arch arteries until between E16.5 and E17.5 (Figure 9), much later than the migration of 
neural crest-derived SMC progenitors into the aortic arch complex.  Lineage tracing using 
Nkx3.2-cre mice (paraxial somitic mesoderm labeling) and WT1-cre mice (mesothelial cell 
labeling) also failed to mark AdvSca1 cells in the aortic root.  We did not test the other 
lineage which contributes SMCs to the aorta and other great vessels, anterior heart field 
(AHF).  Lineage-specific cre mice such as Mef2c-AHF-cre (51, 52) could be used for this 
purpose.  Based on our results with other SMC lineages, it would be very surprising to find 
that AdvSca1 cells in the aortic root are AHF-derived.  Like neural crest cells, AHF-derived 
cells populate the outflow tract beginning much earlier in embryonic development than the 
late stage at which we first observe Sca1 signal (52).  Furthermore, AHF contribution is 
localized to the immediate proximal outflow tract region, whereas AdvSca1 cells are found 
within the adventitia along the entire length of the ascending, transverse, and thoracic 
descending aorta.   
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The experimental results from Hu et al. (7) verified that AdvSca1 cells in adult mice 
do not represent a transient population of bone marrow-derived progenitors that reside 
within the adventitia.  However, the turnover rate of resident AdvSca1 cells within the adult 
adventitia has not been investigated.  Therefore, we can not rule out the possibility that bone 
marrow-derived cells contribute to the initial AdvSca1 colonization of the adventitia and that 
the cells self-renew in situ thereafter.  The primary site of hematopoietic stem cell (HSC) 
activity in the developing mouse embryo migrates from the fetal liver to the bone marrow 
and spleen between E15 and E17.5 (53).  The idea that AdvSca1 cells may be deposited in 
the adventitia during this migration is intriguing.  However, the lack of labeling in Tie2-cre 
lineage tracing experiments suggests that AdvSca1 cells are not of HSC origin.  It remains 
possible that AdvSca1 cells are generated in situ by Shh signaling within the resident 
embryonic adventitial cell population beginning ~E16.5.   
 
Fibroblasts vs multipotent mesenchymal stromal cells vs pericytes: can AdvSca1 cells 
be categorized? 
Fibroblasts are widely distributed connective tissue cells of mesenchymal origin that 
synthesize a variety of extracellular matrix components.  They are considered to typically 
show a flat, spindle-shaped morphology with multiple cellular processes (54).  Multipotent 
mesenchymal stromal cells (MSCs, previously termed mesenchymal stem cells but also 
known variously as mesenchymal stromal cells, bone marrow stromal cells, marrow-isolated 
adult multipotent inducible cells, and multipotent adult progenitor cells (55)) have been 
described as multipotent, plastic-adherent cells with a fibroblast-like appearance that can 
differentiate to various connective tissue lineages (56).  Pericytes have traditionally been 
identified as perivascular cells with an extensively branched morphology that establish 
intimate contact with underlying endothelial cells in order to provide support to the 
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microvessels (57, 58).  Yet beneath these simplistic definitions lie multiple studies 
attempting to characterize these cell types, often with overlapping observations. 
Unfortunately, one characteristic common to fibroblasts, MSCs, and pericytes is the 
inability to phenotypically “define” the cell type.  Many of the criteria used currently refer to 
the behavior of isolated cells in vitro, which is obviously not ideal for tracing the activity and 
responses of the cells in vivo.  Fibroblasts are often identified by the absence of markers for 
other cell lineages (59), yet they can also adopt a myofibroblast phenotype which shares 
features of smooth muscle differentiation.  Recent reviews have highlighted a more 
standardized basic set of marker criteria for each cell type, which is listed in Table 1. 
 
Myofibroblasts (60) Multipotent mesenchymal stromal cells (61) Pericytes (58) 
Vimentin positive CD73+ Smooth muscle α-actin 
Smooth muscle α-actin 
positive CD90
+ (Thy1) Desmin 
Smooth muscle myosin 
negative CD105
+ (endoglin) NG2 (chondroitin sulfate proteoglycan 4) 
Non-muscle myosin positive CD45-  PDGF receptor β 
Virtually no desmin CD34- Regulator of G-protein signaling 5 (RGS5) 
Fibronectin positive CD14- or CD11b-  
 CD19- or CD79α-  
 HLA-DR-  
 
Table 1.  Criteria for cellular classification based on marker expression. 
 
The heterogeneity of the cell populations referred to as fibroblasts, MSCs, or 
pericytes adds to the difficulty in establishing generally applicable classification criteria.  
Moreover, there is considerable overlap between the localization and differentiation potential 
of these cell types.  For example, Song et al. characterized the perivascular cells in mouse 
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pancreatic islet tumors.  By sorting first on the basis of PDGFRβ expression, they found that 
only a subset (14-15%) of the PDGFRβ+ perivascular cells expressed markers of “mature” 
pericytes, including desmin, NG2, or SMαA.  Moreover, some mature pericytes did not 
express PDGFRβ.  The authors suggest that the PDGFRβ+ perivascular cells in the tumor 
actually represent a population of progenitors with the capacity to differentiate to desmin, 
NG2, and SMαA-positive pericytes (49).  MSCs are increasingly considered to reside within 
a perivascular niche (reviewed in (57)) and there have been some reports of MSCs that 
express pericyte markers (62).  In addition, at least subsets of pericytes retain mesenchymal 
multipotentiality.  Fibroblasts/myofibroblasts are among the potential differentiation fates that 
pericytes can adopt in vitro (63). 
Cells such as AdvSca1 cells or the PDGFRβ+ perivascular cells characterized by 
Song et al. do not fit neatly into one particular category.  Given the considerable overlap 
between fibroblasts, MSCs, and pericytes, it may be more conceptually straightforward to 
envision a spectrum of cell identity with multiple intermediate phenotypes.  AdvSca1 cells 
share many characteristics with MSCs and pericytes, including the ability to differentiate 
along adipogenic and osteogenic lines.  Indeed, our results from the Matrigel plugs suggest 
that differentiation to a mature pericyte is one potential fate of AdvSca1 cells in vivo.  Are 
AdvSca1 cells then distinct from the “adventitial fibroblasts” so frequently mentioned in the 
literature?  Lacking a more specific definition of a fibroblast, it is difficult to draw a definitive 
conclusion.  However, several observations argue against the characterization of AdvSca1 
cells as typical connective tissue fibroblasts.  Sca1+ cells can be identified in the aortic 
adventitia only at ~E17.5 and later (Figure 9).  Yet vessel cross sections from earlier 
timepoints, as well as sections from Shh-/- vessels, indicate that there are adventitial cells 
present even in the absence of AdvSca1 cells (Figure 12 and data not shown).  When 
AdvSca1 cells are isolated and cultured, ~20-30% of the cells lost Sca1 expression but did 
not upregulate SMC markers.  Although there is no direct evidence, it is reasonable to 
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hypothesize that at least a subset of those cells adopt a more typical fibroblast phenotype 
under in vitro culture conditions.  Finally, AdvSca1 cells have the potential to become fully 
differentiated SMCs in vitro, as evident from the expression of SM-MHC (Figure 20).  
Myofibroblasts express some SMC marker genes such as SMαA but do not fully 
differentiate.   
 
AdvSca1 growth factor response in vitro and in vivo 
When we treated AdvSca1 cultures with PDGF-BB, we did not observe a robust 
change in Sca1 or SMαA expression (Figures 18 and 24).  These results contrast with data 
reported by Hu et al. in which PDGF-BB treatment induced large increases in the expression 
of SMαA, calponin, and SM-MHC (7).  There are a couple of methodology differences that 
could account for the variation.  In order to isolate AdvSca1 cells, Hu et al. first explanted 
adventitial tissue from the aortic arch and root, allowing cellular outgrowth in a stem cell 
medium containing leukemia inhibitory factor (LIF) and β-mercaptoethanol.  Cells grown out 
from the explant were then dispersed with trypsin and immunomagnetically selected for 
Sca1 expression.  Sca1+ cells were expanded through at least one passage before use in 
experiments (7). 
In contrast, we used immunomagnetic selection to isolate Sca1+ cells from a 
suspension of aortic adventitial cells.  Isolated cells were placed in culture and used without 
passage.  In our hands, culturing AdvSca1 cells in media containing LIF and β-
mercaptoethanol did not alter the proportion of cells that lost the Sca1+ phenotype and 
upregulated SMαA (data not shown).  The behavioral differences in the cells isolated by 
these two methods may indicate an interesting heterogeneity in the population of adventitial 
cells selected by Sca1 expression.  By isolating Sca1+ cells from explant cultures, Hu et al. 
may have excluded a subset of AdvSca1 cells that are more prone to in vitro differentiation, 
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which we observe as cells that upregulate SMαA without any additional exogenous 
treatment.  The potential heterogeneity of AdvSca1 cells is further discussed below.   
One other important difference is that Hu et al. were isolating AdvSca1 cells from 
ApoE-/- mice, whereas the cells in our studies were from wild-type mice.  In follow-up work 
to the initial characterization of AdvSca1 cells, Mayr et al. compared the proteomes of 
ApoE+/+ and ApoE-/- SMCs to SMCs derived from adult ApoE-/- AdvSca1 cells.  Unlike 
Sca1+ progenitors derived from embryonic stem cells, ApoE-/- AdvSca1 cells proteomically 
resembled ApoE-/- SMCs following PDGF-BB treatment.  Notably, there were distinct 
differences from wild-type SMCs (64).  However, a functional or proteomic comparison of 
AdvSca1 cells from wild-type versus ApoE-/- mice has yet to be performed.   
Basic fibroblast growth factor (FGF2) is a mitogen for both endothelial cells and 
mural cells (65) and has been shown to promote angiogenesis in Matrigel plugs as well as 
other in vivo models (66).  FGF2 mRNA is found almost ubiquitously throughout tissues, 
including all cells of the artery wall (67, 68), yet the protein itself is often localized to the 
extracellular matrix (69, 70).  Injury to the vessel wall, however, causes the increase of 
FGF2 expression (71) and the release of FGF2 protein (72).  Significantly, Cuevas et al. 
found that infusion of FGF2 onto the adventitia of rat carotid arteries induced extensive cell 
proliferation and a robust (>10-fold) expansion of the vasa vasorum.  The expanded 
microvasculature had capillaries and sinusoids with vessel walls composed of endothelial 
cells, pericytes, and in some cases multiple layers of SMCs (68).  In our evaluation of 
AdvSca1 differentiation in the in vivo Matrigel plug assay, we used FGF2 to create an 
angiogenic environment.  Under these conditions, AdvSca1 cells differentiated to mural cells 
and contributed to the formation of a vascular network.  At the moment, we do not know 
whether FGF2 acts directly on AdvSca1 cells or if they respond to other signals within the 
angiogenic environment.  It would be very interesting to test whether AdvSca1 cells in the 
intact adventitia respond to injury or FGF2 infusion by contributing to the expansion of vasa 
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vasorum microvessels.  The release of FGF2 may be one factor that promotes neoadventitia 
formation following vessel injury.  It will therefore be important to evaluate the effect of FGF2 
on AdvSca1 cell proliferation as well as mural cell differentiation. 
 
Transcriptional regulation of the AdvSca1 progenitor phenotype 
AdvSca1 cells do not express SMC marker proteins in vivo.  It was intriguing, 
therefore, to find that AdvSca1 cells contained transcripts for SRF and myocardin family 
members and were immunopositive for SRF when examined immediately after isolation from 
the artery wall.  These transcription factors are strong activators of SMC gene expression 
(22, 73-75) and are necessary for vascular SMC differentiation in vivo.  Yet SRF also 
interacts with potent transcriptional corepressors, and it is the competition between 
coactivators and corepressors that determines whether SRF-dependent target genes are 
transcribed (74-78).  Indeed, we found that the transcriptional corepressors Msx1, Klf4, and 
FoxO4 were also expressed by AdvSca1 cells.  Msx1 forms a ternary complex with SRF and 
myocardin and inhibits binding of SRF-myocardin to CArG box motifs in SMC target genes 
(41).  Klf4 is a zinc finger-containing protein that binds to a GC-rich element (TCE) and 
inhibits SRF-dependent transcription of multiple SMC marker genes (77).  The forkhead 
transcription factor FoxO4 interacts with myocardin and inhibits its coactivator function for 
SRF-dependent SMC gene expression (43).  
These results are reminiscent of a report by Matsuura et al. (79), showing that Sca1+ 
cells from adult mouse hearts express Nkx2.5 and GATA4, two transcription factors 
important for cardiac myocyte differentiation, yet they do not express markers of 
differentiated myocardial cells.  Heart-derived Sca1+ cells differentiate to beating 
cardiomyocytes when exposed to oxytocin in vitro, thus confirming their cardiogenic 
potential (79).  These findings in heart and artery wall suggest a model in which Sca1+ 
progenitor cells in postnatal tissues are specified for certain cell fates by expression of 
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transcription factors that are required for those fates.  The maintenance of a SMC progenitor 
phenotype may therefore critically depend on expression of transcriptional corepressors that 
block SRF-dependent transcription and recruit chromatin remodeling complexes to silence 
gene expression. 
 
The Matrigel plug assay as a test of AdvSca1 in vivo differentiation potential 
Matrigel is solubilized basement membrane that is prepared from Engelbreth-Holm-
Swarm mouse sarcoma.  Laminin is the major component, followed by collagen IV, heparin 
sulfate proteoglycans, and entactin/nidogen (80).  In growth factor-reduced preparations, 
FGF2 (0-0.1 pg/mL), epidermal growth factor (<0.5 ng/mL), insulin-like growth factor 1 (5 
ng/mL), PDGF (<5 pg/mL), nerve growth factor (<0.2 ng/mL), and TGF-β (1.7 ng/mL) are 
also present.  The Matrigel plug angiogenesis assay (44) is commonly used to test the 
angiogenic (or antiangiogenic) potential of growth factors and chemical compounds, as well 
as to evaluate the behavior of cells suspended in the plug.  As an in vivo assay to test 
AdvSca1 behavior and differentiation potential, Matrigel plugs offer both advantages and 
disadvantages.  By isolating AdvSca1 cells for the Matrigel plugs from genetically labeled 
mice, we can easily differentiate AdvSca1-derived cells in the plug from host-derived cells.  
The AdvSca1 cells are incubated in an in vivo environment, as opposed to the highly 
artificial conditions in a culture dish.  The implantation procedure is relatively non-invasive 
and does not induce a robust inflammatory response.  Finally, the possibility that AdvSca1 
cells actively participate in angiogenic events in the adventitia holds great developmental 
and pathological relevance (see further discussion in Chapter 5).  Thus, it is logical to test 
AdvSca1 behavior in a well-established angiogenesis assay.   
There are several factors that are important to keep in mind when interpreting the 
Matrigel plug results.  Foremost, the Matrigel environment is going to differ from the 
adventitia in multiple ways.  The adventitia is generally considered to have a collagen-rich 
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extracellular matrix (81), while the primary component of Matrigel is laminin.  The thickness 
and subcutaneous location of a Matrigel plug may also result in substantial differences in 
oxygen levels compared to the arterial adventitia.  The availability and concentrations of 
growth factors are almost certainly going to differ between the adventitia and the Matrigel 
plug.  Finally, the AdvSca1 cells in the Matrigel plug are initially suspended at a 
concentration that would not promote cell-cell contact or readily allow diffusion of secreted 
factors between cells.  Each individual AdvSca1 cell is thus initially influenced only by 
autocrine signaling and factors available from the Matrigel itself.   
Bearing in mind the potential differences between the adventitia and the Matrigel, we 
can nonetheless draw valuable insight from the in vivo transplant assay.  The FGF2 in the 
plugs provides an angiogenic signal that induces cells from the host tissue to infiltrate the 
Matrigel and assemble into vascular structures, a process which can not easily be 
duplicated in a culture dish.  AdvSca1-derived cells integrate into the microvessels (Figures 
21-23) and may also promote efficient vascular assembly in the early stages by secreting 
additional proangiogenic factors.  We observed differentiation of AdvSca1 cells to mural 
cells (Figure 23), which supports our in vitro data demonstrating differentiation to SMC-like 
cells.  Furthermore, our preliminary data suggest that AdvSca1 cells also have the in vivo 
potential to differentiate to macrophages and adipocytes (Supplemental Figure 1 in 
Appendix A), two cell types extremely relevant to adventitial and periadventitial tissue.  
While additional models will certainly be required to fully explore the behavior of AdvSca1 
cells in vivo, the participation of AdvSca1 cells in Matrigel plug angiogenesis gives us a 
valuable clue to a potential role for the cells in the adventitia in general and in remodeling of 
the vasa vasorum microvasculature in particular. 
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AdvSca1 self-renewal versus differentiation 
Sca1 is a cell surface marker commonly associated with stem/progenitor 
populations, but it is expressed by multiple cell types (2).  Morphologically, Sca1+ cells in the 
adventitia in vivo appear grossly uniform, having a slightly flattened and elongated shape 
(see Supplemental Figure 2 in Appendix A).   Yet none of our data rules out the possibility 
that there are intrinsic differences between adventitial cells which both express Sca1.  When 
AdvSca1 cells are directly isolated from the adventitia and placed in culture, a subset of the 
cells differentiates to SMC-like cells that express SMαA (Figure 16).  Whether an individual 
cell differentiates or retains Sca1 expression under these conditions might be a stochastic 
choice, or alternatively the fate of each cell may be influenced by the differential expression 
of factors such as growth factor receptors or SRF cofactors.   In support of the latter 
possibility, culturing AdvSca1 cells in conditions promoting adipogenic or osteogenic 
differentiation also induces only a fraction of the cells to adopt those fates (Figure 19).  An in 
vitro clonal assay would begin to address the question of whether each individual AdvSca1 
cell has the potential for self-renewal as well as SMC, adipogenic, and osteogenic 
differentiation.  It will be critical, however, to first gain a better understanding of the 
environment to which the cells are exposed within the adventitia in vivo.   When isolated for 
culture, AdvSca1 cells are removed from the influence of cell-cell contacts, extracellular 
matrix interactions, growth factor and cytokine exposure, and other potentially important 
elements of the adventitial environment.  Any or all of these components may be critical for 
regulating AdvSca1 phenotype and the balance between self-renewal and differentiation.  
Using culture conditions that reproduce important elements of the in vivo environment will 
lead to a better understanding of AdvSca1 behavior in the artery wall.   
During flow-induced carotid artery remodeling, one of the earliest responses is 
proliferation within the adventitial layer, resulting in neoadventitia formation by one week 
post-ligation.  Our results indicate that AdvSca1 cells proliferate during this time period 
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without undergoing significant differentiation to a myofibroblast or SMC phenotype (Figures 
25 and 26).  More extreme responses have been observed in other models of arterial injury, 
particularly balloon overstretch models which mimic angioplasty (82-86).  It seems 
reasonable to draw a correlation between the severity of the arterial injury and the degree of 
adventitial response.  Balloon injuries, which circumferentially distend the vessel and often 
denude the endothelial layer, are far more damaging to the vessel wall than the initial 
increase in pulsatile pressure in the flow-reduction.  It would be informative to compare the 
early arterial response to balloon injury versus flow-reduction with regards to changes in 
signaling factors and adventitial gene expression.  Factors that are altered by balloon injury 
but not flow-reduction may be candidates for provoking AdvSca1 differentiation in vivo.  
Likewise, any differences between flow-reduced vessels and uninjured vessels may play a 
role in promoting AdvSca1 proliferation. 
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 CHAPTER 4 
Krüppel-like factor 4 contributes to repression of smooth muscle genes and helps 
maintain the capacity for self-renewal in AdvSca1 cells  
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Introduction 
Krüppel-like factors (Klf) are transcriptional regulators that play diverse roles in 
differentiation, development, proliferation, and apoptosis (1, 2).  Klf family members have 
three highly homologous zinc fingers at the carboxy terminus of the protein that mediate 
binding to DNA, and as a result, family members bind very similar consensus DNA sites.  In 
contrast, the non-DNA binding regions of the Klf proteins are highly divergent (3).  Many 
family members can function as both transcriptional repressors and activators.   
 Murine knockouts of individual Klf family members result in diverse phenotypes (4).  
Notably, KLF2-/- mice die between E12.5 and E14.5 from severe intra-embryonic and intra-
amniotic hemorrhaging.  They display normal vasculogenesis and angiogenesis, but fail to 
properly recruit and organize supporting SMCs and pericytes (5).  KLF5 knockout 
blastocysts fail to implant, resulting in early embryonic lethality (6, 7).  Furthermore, Klf5 may 
play an essential role in the maintenance of pluripotent embryonic stem (ES) cells by 
suppressing the expression of differentiation-related genes (7).  KLF5 heterozygous mice 
are viable but display vascular defects, including abnormal thinning of the aortic media and 
adventitia and abrogated response to vessel injury (6).    
 KLF4 knockout mice die shortly after birth from dehydration as a result of defective 
skin barrier formation (8).  No obvious cardiovascular defects were reported in the germline 
knockout mice, but several studies have implicated Klf4 in the regulation of SMC gene 
expression in smooth muscle cells undergoing phenotypic modulation (9-14).  Most recently, 
Yoshida et al reported that KLF4 expression is induced in medial SMCs following carotid 
artery ligation.  Mice with a conditional depletion of Klf4 showed a delay in the repression of 
SMC marker genes, consistent with the reported role of Klf4 as a co-repressor of SRF-
dependent SMC gene expression (13). 
 Coexpression of Klf4 along with Oct4, Sox2, and c-Myc or UTF1 dramtically 
reprograms fully differentiated adult somatic cells to pluripotent embryonic stem cells (15, 
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16).  Klf4 has therefore been referred to as a pluripotency factor, although it clearly has a 
number of important functions in adult cell types, including monocytes (17), sertoli cells (18), 
and epidermal cells (8).  The roles played by Klf4 in cellular reprogramming involve 
transcriptional control pathways for key pluripotency target genes such as Oct4 and Nanog 
(19, 20).  Jiang et al recently reported that Klf2, 4, and 5 function within a Klf-dependent 
transcriptional network to regulate self-renewal in ES cells, and that they display some 
degree of functional redundancy in the control of pluripotency (19).   
 
Hypothesis 
Sca1+ smooth muscle progenitor cells within the arterial adventitia self-renew and 
maintain a “pre-SMC” progenitor phenotype that is poised for signal-responsive SMC 
differentiation.  The transcription factor Klf4 regulates the maintenance of AdvSca1 cells as 
progenitors within the vessel wall by controlling one or both of these processes. 
 
Materials and Methods 
Animals Used:  All protocols were approved by the Institutional Animal Care and Use 
Committee at the University of North Carolina.  KLF4 mice were a gift of Julie Segre, 
National Human Genome Research Institute, and are described in Segre et al. (8). 
Immunofluorescence Staining:  Tissues were fixed for 1 hr in freshly prepared 4% 
PFA, rinsed in PBS, saturated with 20% sucrose for cryoprotection, embedded in agar, and 
frozen in OCT.  Twelve-micrometer cryosections were fixed in methanol at room 
temperature for 5 min, permeabilized with 0.05% Tween-20 (in PBS) for 2 min, rinsed in 
PBS, then blocked in 2% normal goat serum (NGS) or normal donkey serum for 2–8 h.  
Sections were incubated with primary antibodies at 4°C overnight, rinsed twice in PBS + 
0.1% BSA, then incubated with secondary antibodies for 2-8 h at room temperature, 
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protected from light.  Nuclei were counterstained with 10 μg/ml Hoechst 33258 in H2O and 
slides were mounted in Mowiol with 2.5% DABCO. 
For cells in culture, cells were fixed by incubating in freshly prepared 4% PFA for 15 
min at room temperature, then permeabilized with 1:1 methanol/acetone for 1 min.  Cells 
were blocked in 2% normal serum for 1-4 h at 4°C, then incubated with primary antibodies at 
4°C overnight.  After two rinses in PBS + 0.1% BSA, cells were incubated with secondary 
antibodies 1-4h at room temperature protected from light.  Nuclei were counterstained with 
10 μg/ml Hoescht 33258 in H20.  For EdU labeling experiments, cells were incubated with 10 
µM EdU (Invitrogen C10340) for one hour then fixed and stained with the Click-iT Edu 
Imaging Kit according to manufacturer instructions.  After washing in PBS, standard protocol 
was followed to stain with additional primary and secondary antibodies. 
Primary antibodies used for these studies included mouse anti-SMαA (1:100; Sigma 
A2547), rat anti-Sca1 (1:100; BD Pharmingen 553333), mouse anti-FLAG (1:500; Sigma 
F1804), and chicken anti-GFP (1:1000; Abcam ab13970).  All secondary antibodies were 
AlexaFluor-conjugated (Invitrogen) and used at a dilution of 1:500 in PBS.  
Immunofluorescence staining was visualized with a Leica BM IRB inverted epifluorescence 
microscope with images captured by a QImaging Retiga 1300 digital camera or a Olympus 
IX 81-ZDC Inverted Fluorescence Microscope with images captured by a Hammatsu ORCA 
RC camera.  Confocal images were obtained with a Zeiss LSM710 spectral confocal laser 
scanning microscope and processed with Zeiss LSM Image Browser and Adobe Photoshop. 
AdvSca1 Cell Isolation and Culture:  Mice were sacrificed by cervical dislocation and 
perfused through the left ventricle with PBS.  The thoracic aorta was cut at the diaphragm 
and periadventitial fat was cleared from around the vessel.  The aorta was gently lifted away 
from the dorsal body wall, with intercostal arteries trimmed even with aortic wall.  In arch 
region, the superior vena cava and pulmonary artery were cleared and branching arteries 
and ductus arteriosus were trimmed even with the aortic wall.  At the junction with the 
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myocardium, the aorta was cut flush with the ventricular wall and placed in HBSS at 37ºC.  
Before digesting, any remaining fat and coagulated blood were cleared from the tissue. 
Whole aortas were briefly digested in 0.4 mg/mL collagenase in HBSS at 37°C for 6 
min.  Tissue was immediately removed and placed in fresh HBSS at 37°C.  Adventitia was 
gently separated from the media of each aorta by peeling the layer up and over the vessel.  
Adventitias were placed in the second digestion solution of 15 mg/mL collagenase II 
(Worthington, 4176) and cut into small pieces.  Tissue was digested for 2-2.5 hrs at 37°C 
with constant rocking to achieve a single-cell suspension, which was then passed through a 
30 μm pre-separation filter (Miltenyi, 130-041-407).  Filtrate was collected and cells were 
pelleted at 300xg then rinsed in PBS + 0.5% BSA.  Aortic Sca1+ cells were isolated using 
anti-Sca1 immunomagnetic MicroBeads (Miltenyi ) and a MACS cell separation system 
(Miltenyi ) according to manufacturer’s instructions.  Cells were passed over two consecutive 
columns to increase purity of the isolation.  Isolated Sca1+ cells were cultured in DMEM 
(Sigma) plus 10% FBS (HyClone) and 1x antibiotic/antimycotic solution (Gibco) at 37°C, 5% 
CO2.  Cells were seeded in 48-well tissue culture plates at a density of 8x103-1.5x104 cells 
per well, depending on the assay.  
Adenovirus infection:  Purified adenovirus expressing GFP was purchased from the 
UNC Gene Therapy Center Virus Vector Core Facility.  Adenovirus expressing FLAG-KLF4 
under control of the CMV promoter was a gift from Gary Owens, University of Virginia.  
AdvSca1 cells were isolated according to standard procedure and incubated overnight in 
DMEM +10% FBS + 1x antibiotic/antimycotic.  The next day, adenovirus was added to 300 
MOI with 1.2 µg/mL polybrene (Sigma H9268).  Cells were incubated for 5 d with virus and 
then fixed for immunostaining.   
RT-PCR Analysis:  Total cellular RNA was isolated by guanidinium isothiocyanate 
denaturation and phenol/chloroform extraction as described (21). Two-step RT-PCR was 
carried out with the GeneAmp RNA PCR kit (Applied Biosystems) according to the 
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manufacturer’s instructions.  The sequences for primers used for RT-PCR analysis of gene 
expression are provided in Appendix B.  Unless otherwise indicated, primer sequences were 
designed for this study based on mouse genomic sequence available through Ensembl 
(release 45, June 2007; (22)). Primers were designed with the aid of Primer3 software (v. 
0.4.0) (23).   
siRNA Transfection:  AdvSca1 cells were isolated and cultured according to standard 
protocol until cells reached 60-70% confluency.  Medium was replaced with DMEM + FBS 
(no antibiotics) and cells were incubated overnight.  The following day, cells were 
transfected with Dharmafect4 transfection reagent (0.02 µL per 100 µL transfection medium; 
Thermo Scientific) and siGENOME SMARTpool siRNAs (100 nM; Thermo Scientific).  An 
siRNA that does not target known mouse genes was used as a negative control 
(AAUAGAUGAGAGACACACAGCTT, 100 nM; MWG Biotech).  Cells were incubated for 48-
72 h, as indicated.   
 
Results 
Knockdown of Klf4 in vitro causes loss of Sca1 expression 
KLF4 is highly expressed in AdvSca1 cells, downregulated as the cells differentiate 
in culture, and expressed only at extremely low levels in SMCs of the aortic media (Figure 
20).  Based on its known functions as a co-repressor of SRF-dependent SMC gene 
transcription and as a regulator of self-renewal in embryonic stem cells (ESCs), we sought 
to test whether AdvSca1 cells rely on Klf4 activity to maintain their status as SMC progenitor 
cells.  We used a siRNA-mediated approach in vitro to evaluate the effects of loss of Klf4 
activity.  At 72hrs after siRNA transfection, KLF4 mRNA expression is >90% reduced 
(Figure 27F).  Klf4 knockdown decreases Sca1 mRNA expression (Figure 27F) as well as 
reducing the number of Sca1-positive cells, as evaluated by immunofluorescence staining 
(Figure 27 B,D).   While there appears to be an increase in SMα-actin mRNA expression 
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(Figure 27F), the percentage of total cells that exhibit SMα-actin-positive staining in a 
definite cytoplasmic stress fiber filament pattern did not increase upon Klf4 knockdown 
(Figure 27E).  This may suggest that SMα-actin expression remains repressed in a subset of 
AdvSca1 cells in spite of Klf4 knockdown, perhaps due to the activity of other SRF co-
repressors.  Alternatively, the 72 hr time point used for these experiments may be too short 
to see nascent SMα-actin protein incorporated into cytoplasmic filaments.  Increased levels 
of SMα-actin mRNA (Figure 27F) would argue that Klf4 knockdown produced a 
corresponding increase in SMC marker expression.  However, evaluation of SMα-actin 
mRNA and protein expression at additional time points will be necessary to solidify these 
conclusions. 
Work by Jiang et al. suggests that Klf4 plays a role in regulating the self-renewal 
capacity of pluripotent stem cells (19).  We used EdU (an analog of BrdU) to examine the 
proliferation index in siRNA-treated AdvSca1 cultures.  At 72 hrs after siRNA transfection, 
we found ~90% reduction in proliferating Sca1+ cells compared to control samples (Figure 
27G).  In comparison to the ~73% reduction predicted by the overall decrease in the number 
of Sca1+ cells, these results are consistent with loss of Klf4 activity causing a defect in the 
ability of AdvSca1 cells to proliferate while maintaining a Sca1+ progenitor phenotype.  
Additional experiments will be required to substantiate a role for Klf4 in the regulation of true 
AdvSca1 self-renewal. 
Klf2 and Klf5 can functionally substitute for Klf4 activity in the maintenance of ESC 
self-renewal (19), therefore we also tested whether knockdown of multiple Klf’s would 
synergistically promote AdvSca1 differentiation or self-renewal defects.  While KLF5 
expression was also reduced following siRNA treatment, we did not observe any additive 
effects upon simultaneous knockdown of Klf4 and Klf5 (Figure 27).  We were unable to 
achieve knockdown of Klf2 using these methods.  Overall, these results suggest that Klf4 
plays an important role in the maintenance of AdvSca1 progenitor phenotype.  Based on
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Figure 27.  Effects of Klf4 knockdown on AdvSca1 cells in vitro.  Cultured AdvSca1 cells 
were transfected with siRNAs targeting KLF2, KLF4, or KLF5, as indicated, and evaluated 
72 hrs after siRNA transfection.  (A-C) Representative images from treated cultures with 
immunostaining for SMα-actin (green), Sca1 (red), and DAPI (blue).  (D) Sca1-positive and 
(E) SMα-actin-positive cells from each treatment group were counted and normalized to total 
cell numbers.  (F) RNA was collected from treated cells and RT-PCR used to evaluate 
knockdown efficiency and changes in Sca1 and SMα-actin gene expression.  (G) Cell 
proliferation was evaluated by EdU incorporation and co-staining for Sca1.  Values are 
expressed as percent of total EdU-positive cells expressing Sca1.  Overall, Klf4 knockdown 
decreases Sca1-positive cells in AdvSca1 cultures. 
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these preliminary findings, these effects are specific to Klf4, as the presence or absence of 
Klf2 and Klf5 did not impact the observed changes in Sca1 expression or the number of 
SMα-actin-positive cells.   
 
Overexpression of Klf4 prevents AdvSca1 differentiation to smooth muscle cells 
AdvSca1 cells differentiate to SMC-like cells in vitro, a change accompanied by 
downregulation of KLF4.  Whether the decrease in KLF4 expression during these initial 
changes in cell phenotype is a cause or effect of AdvSca1 differentiation is unclear.  Since 
knockdown of Klf4 promoted the loss of a Sca1+ progenitor phenotype, we also tested 
whether overexpression of Klf4 in AdvSca1 cells in vitro would prevent their differentiation.  
Cells overexpressing adenovirus-driven FLAG-KLF4 were co-stained with SMα-actin or 
Sca1 (Figure 28) as markers of cellular identity.  GFP adenovirus was used as a 
 
 
 
Figure 28.  Evaluation of SMα-actin and Sca1 expression in cells overexpressing Klf4.  
Cultured AdvSca1 cells were infected with adenovirus expressing GFP (control) or FLAG-
KLF4.  After 5 d, cells were fixed, stained for SMα-actin (SMA) or Sca1, and evaluated for 
adenovirus co-expression.  Values are expressed as fraction of adenovirus-positive cells 
expressing either SMα-actin or Sca1, normalized to control.  Klf4 overexpression decreases 
the number of SMα-actin-positive cells but does not prevent or reverse the downregulation 
of Sca1. 
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control for comparison.  If Klf4 is functioning as a co-repressor of SRF-dependent 
transcription in AdvSca1 cells, we would predict that the expression of SMC marker genes 
such as SMα-actin would be blocked by overexpression of Klf4.  Indeed, our results indicate 
that the number of cells co-expressing FLAG-KLF4 and SMα-actin was significantly reduced 
compared to control virus (Figure 28).  Interestingly, however, we did not observe an 
increase in the number of cells co-expressing FLAG-KLF4 and Sca1, as would be expected 
if overexpression of Klf4 was sufficient to maintain AdvSca1 cells as Sca1+ progenitors in 
vitro.  While not conclusive, these results suggest that Klf4 overexpression in AdvSca1 cells 
can block the expression of SRF-dependent marker genes but that additional factors are 
required to maintain a Sca1+ progenitor phenotype when AdvSca1 cells are removed from 
their native adventitial environment. 
 
 
Discussion 
Role of Klf4 in regulation of smooth muscle gene expression 
 KLF4 was initially identified as a gene that is highly expressed in growth-arrested 
NIH 3T3 cells but nearly undetectable in exponentially proliferating cells (24).  Klf4 was first 
connected to SMC gene transcription in work by Adam et al, where they found that Klf4 
bound to a GC-rich transforming growth factor β (TGF-β) control element in the SM22α 
promoter, repressing its activity (9).  Subsequent work suggests that Klf4 may actually have 
multiple mechanisms for repression of SMC genes.  SMCs overexpressing Klf4 in vitro 
displayed decreased expression of myocardin (11) and distinct reductions in histone H4 
acetylation at the SMα-actin and SM-MHC promoters (25). 
 The striking reduction in Sca1 expression upon knockdown of Klf4 in AdvSca1 cells 
is reminiscent of the effect of treating cultured AdvSca1 cells with TGF-β (Figure 19), which 
also causes a loss of Sca1 expression.  There is a plausible link between these two 
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observations.  The TGF-β control element (TCE) found in the promoters of SMC genes such 
as SMα-actin and SM22α is critical for expression of these genes in vitro and in vivo (9, 26).  
Klf4 has been shown to bind to the TCE and exert repressive effects on TGF-β-stimulated 
gene expression (9, 10, 26).  Initially, TGF-β treatment was observed to decrease KLF4 
gene expression (9) but recently, Kawai-Kowase et al. reported that the inductive effects of 
TGF-β on SMα-actin gene expression are mediated through the SUMO E3-ligase PIAS1.  
The authors went on to show that PIAS1 promotes the degradation of Klf4, which requires 
the SUMO E3-ligase activity (27).  Klf4 can activate its own promoter (28), potentially 
explaining the observed reduction in KLF4 gene expression following TGF-β stimulation.  It 
will be interesting to further investigate a possible link between TGF-β, Klf4, and 
differentiation of AdvSca1 cells. 
  
AdvSca1 cells depend on Klf4 to maintain a progenitor phenotype 
 Drawing a distinction between loss of the capacity for self-renewal and promotion of 
differentiation can be conceptually challenging.  EdU incorporation reveals fewer 
proliferating Sca1+ cells in Klf4 knockdown cultures, consistent with a decreased ability of 
dividing AdvSca1 cells to maintain their progenitor phenotype.  Yet the possibility remains 
that loss of Klf4 may simply remove a block preventing differentiation rather than 
representing the loss of a factor that actively promotes the expression of genes that 
maintain the progenitor phenotype.  Knockdown of Klf4 followed by challenging the cells 
with factors that promote the adoption of cell fates other than smooth muscle may be useful 
in determining if loss of the progenitor phenotype makes AdvSca1 cells vulnerable to other 
instructive cues or whether Klf4 knockdown promotes only the smooth muscle fate.   
Studies into the mechanisms controlling self-renewal of other adult progenitor cells 
such as hematopoietic stem cells and myogenic satellite cells have illustrated the critical 
interplay between the external niche environment and transcription factors controlling cell-
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type-specific gene expression (reviewed in (29-31)).  In muscle satellite cells, the paired box 
7 (Pax7) gene appears to be a critical regulator of both cell fate and self-renewal.  Quiescent 
satellite cells express Pax7 (32), and levels of the myogenic regulatory factor MyoD are very 
low or undetectable (33).  When satellite cells are activated, MyoD is rapidly induced and 
Pax 7 levels begin to decrease.  The activity of MyoD is regulated at multiple levels (34), 
including repression by Pax7 itself (35).  Thus, one could consider Pax7 as a central factor 
in a network of muscle satellite cell transcriptional regulation, with roles in both repression of 
differentiation and control of self-renewal.  None of our results rule out such a dual role for 
Klf4 in AdvSca1 cells, with functions in the regulation of both self-renewal and repression of 
SMC gene expression.   
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Summary of results 
1) Beginning at E15.5 and persisting into adulthood, active Hh signaling in the artery wall 
is restricted to the adventitial compartment, as demonstrated by Ptc1-, Ptc2-, and Gli1-
lacZ reporter mice.  Hh-responsive adventitia is found throughout the arterial system, 
including the aorta, pulmonary trunk, coronary, femoral, mesenteric, and intercostals 
arteries.  Shh protein is concentrated at the border between the media and adventitia.   
2) Sca1+ vascular progenitor cells (AdvSca1 cells) reside within the adventitia beginning 
between E16.5 and E17.5 and persisting through adulthood.  RT-PCR analysis 
demonstrates that AdvSca1 cells express multiple Hh signaling pathway components.  
In Shh-/- mice, AdvSca1 cells are drastically reduced in number, and in vitro 
experiments using cyclopamine to inhibit Hh pathway activity suggest that Shh 
signaling plays an important role in promoting the proliferation of AdvSca1 cells. 
3) Lineage tracing analyses demonstrate that AdvSca1 cells are derived from different 
embryonic origins than their neighboring medial SMCs.  AdvSca1 cells were also not 
labeled by Tie2-cre expression, indicating that they are not of hematopoietic stem cell 
origin. 
4) AdvSca1 cells do not express SMC markers in vivo, yet a subset of isolated AdvSca1 
cells in culture loses Sca1 expression and upregulates SMC marker genes.  RT-PCR 
analysis indicates that AdvSca1 cells express SRF and SRF cofactors thought to be 
sufficient for SMC differentiation, but the presence of SRF co-repressors, which are 
also expressed in vivo, may prevent the expression of SMC marker genes.  As 
AdvSca1 cells differentiate in vitro, the expression levels of co-repressors are 
decreased and levels of co-activators are increased. 
5) In vitro and in vivo experiments indicate that AdvSca1 cells have SMC and mural cell 
differentiation potential.  In addition, evidence suggests that at least some AdvSca1 
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cells can produce osteogenic cells in vitro, endothelial cells and possibly macrophages 
in vivo, and adipogenic cells both in vitro and in vivo.  In Matrigel plugs in vivo, 
AdvSca1 cells localize to the perivascular region of newly formed microvessels and 
express markers commonly associated with perictyes.   
6) Knockdown of Klf4 in vitro drastically decreases the number of AdvSca1 cells that 
retain a Sca1+ progenitor phenotype, causes defects in Sca1+ cell proliferation, and 
increases SMα-actin mRNA levels.  Conversely, overexpression of KLF4 blocks SMα-
actin expression.   
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Figure 29.  Working model of AdvSca1 regulation.  Shh protein concentrated at the border 
between the arterial media and adventitia signals to multiple cell types within the adventitia.  
Resident within this Hh-responsive zone are Sca1+ vascular progenitor cells with the 
capacity for self-renewal and differentiation to multiple vascular cell types.  The transcription 
factor Klf4 is highly expressed in AdvSca1 cells and may serve as a central factor in a 
regulatory network controlling the expression of cell-type specific genes and progenitor cell 
self-renewal.   
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Future directions 
 
Hedgehog signaling and development of the artery wall 
The developmental localization of Hh signaling and Shh protein to the adventitia is 
striking.  While Shh is clearly important for the proper establishment of AdvSca1 cells, this 
role is likely to be secondary to other functions for Shh signaling in the vasculature.  Indeed, 
other data from our lab demonstrate that multiple adventitial cell types are Hh-responsive at 
early postnatal timepoints, including macrophages, adipocytes, and perineural cells.  
Experiments are currently underway to evaluate the production of Shh ligand by different 
adventitial cell types to determine if Hh-responsive cells also synthesize ligand.  These 
studies use Shh-EGFP mice in which enhanced green fluorescent protein is knocked into 
the endogenous Shh gene locus, replacing the first 35 base pairs of exon one following the 
ATG (1), and results will be verified by in situ hybridization for Shh mRNA.   
Hedgehog signaling could be critical for the development and/or function of any of 
the responsive cell types.  In addition to its roles in progenitor cell maintenance, 
proliferation, and survival, Shh has been demonstrated to have chemoattractive qualities for 
neural progenitor cells (2) and monocytes (3) and influences the migration of several other 
cell types (4).  Therefore, one possible role of Shh expression in the adventitia during 
development is to recruit and assemble the various cell types that are integral to a functional 
adventitial compartment.  Genetic tools will be useful in targeting Hh pathway activation or 
knockout in specific cell types such as SMCs, macrophages, and adipocytes.  Cell type-
specific cre mice used in combination with floxed-Smo (5) or mice that conditionally express 
a constitutively active form of Smo (6) will allow evaluation of the effects of Hh signaling 
deletion or constitutive activation, respectively.   
The role of Hh signaling in SMC differentiation is intriguing.  Preliminary data from 
our lab suggest that multiple Hh pathway components are downregulated as cells undergo 
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SMC differentiation (see Supplementary Figure 3 in Appendix A), indicating that mature 
vascular SMCs may have limited or no ability to respond to Hh ligands.  This parallels the 
observations of Yu et al. in the kidney and ureter, where SMC progenitors, but not 
differentiated SMCs, respond to paracrine Shh signaling (7).   
Another possible role for Shh signaling in the adventitia is to promote and regulate 
the development of the vasa vasorum.  Angiogenic effects of Shh are mediated through 
interstitial fibroblasts, which upregulate VEGF, angiopoietin-1, and angiopoietin-2 in 
response to Shh treatment (8).  The development of the vasa vasorum has not been well 
characterized in mice; therefore it will be very interesting to conduct a detailed analysis of 
the timing and construction of the vascular plexus in both wild-type and Shh-/- embryos.  
These studies could then be further extended to test for a link between the formation of the 
vasa vasorum and the appearance of AdvSca1 cells in the adventitia.  Pericytes depend on 
endothelial-derived PDGF-B for proper recruitment and function (9, 10) and given the strong 
expression of PDGFR-β by AdvSca1 cells, it is logical to speculate that PDGF signaling is 
also important in their regulation.  Colonization of the adventitia by AdvSca1 cells only after 
vasa vasorum establishment may also provide an explanation for the appearance of 
AdvSca1 cells relatively late in embryonic development.   
 
 
Genetic targeting of AdvSca1 cells 
 Further investigation into the mechanisms and factors that regulate AdvSca1 self-
renewal and differentiation will have important implications for vascular disease and 
development.  Examination of AdvSca1 phenotype in global knockout mice provides useful 
information regarding the development of the cells when the factor of interest is 
constitutively absent.  However, these models are often limited by other phenotypes that 
cause severe defects or embryonic lethality, complicating the interpretation of the effect on 
AdvSca1 cells and limiting the time window in which they can be examined.   
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One strategy that has been used to more specifically target adventitial cells is the 
direct application of adenovirus or plasmid vector to the adventitial surface of the artery wall 
(11-13).  Control experiments using reporter genes confirmed that exogenous gene delivery 
was limited to adventitial cells and indicated that gene expression persists for at least 14d 
following application.  This method is best suited to gene overexpression rather than 
removal of gene function, although it could be adapted for delivery of chemical inhibitors 
such as cyclopamine or TGF-β receptor kinase inhibitors.   Due to the inherently invasive 
nature of exposing the arterial adventitia for direct application of factors, it is a good choice 
for use in combination with surgical vascular injury models such as carotid artery flow-
reduction (see below).  
For gene deletion, a genetic approach using mice with conditionally expressed cre 
recombinase in combination with a floxed gene of interest would be optimal.  This will 
require the identification of an appropriate promoter that can be used to drive cre expression 
in AdvSca1 cells.  Sca1 itself is a risky choice because it is expressed in multiple different 
cell types (14).  For example, Sca1 expression by hematopoietic cells and adipose stromal 
cells could complicate labeling experiments and increase the possibility of deleterious side-
effects of targeted gene knockout that are unrelated to AdvSca1 functions.  An unbiased 
screen for genes expressed by AdvSca1 cells would reveal candidates.  The ideal factor will 
be as specific as possible to AdvSca1 cells and should not be expressed in SMCs or other 
arterial cells.  A transgenic construct in which cre expression is driven by the promoter of 
interest in an inducible fashion will further help to minimize effects on non-AdvSca1 cells.  A 
transgenic mouse with cre expression in AdvSca1 cells would be a valuable tool that could 
be used in combination with existing flox lines, giving us the ability to evaluate the effects of 
Hh pathway deletion, constitutive activation, and deletion of one or more Krüppel family 
members without the complications of embryonic lethality and effects on other cell types.  
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Furthermore, inducible cre expression would allow us to genetically mark AdvSca1 cells and 
follow their fate during postnatal development and adventitial response to vascular injury. 
 
AdvSca1 cell differentiation potential 
 In the course of these studies, we have observed isolated AdvSca1 cells differentiate 
to SMCs and osteogenic cells in vitro, pericytes, endothelial cells, and macrophages in vivo, 
and adipocytes both in vitro and in vivo.  As discussed above, all of these cell types are 
relevant to the adventitia and artery wall.  Whether an individual AdvSca1 cell is capable of 
differentiating to all the cell types we observed or if the AdvSca1 population is 
heterogeneous with respect to differentiation potentials is not yet entirely clear.  In addition, 
the extent to which the assay environment determines the cell types that are produced by 
AdvSca1 cells needs to be carefully considered.  It will be important to expand our in vivo 
analysis of AdvSca1 potential using models that complement the Matrigel plug assay.  To 
this end, the methods used for the Matrigel plug assay could easily be adapted to test the 
behavior of AdvSca1 cells in other matrices.  Collagen is an abundant component of the 
adventitial extracellular matrix, so testing the differentiation behavior of AdvSca1 cells 
suspended in purified collagen may be a relevant alternative to Matrigel.  Fibrin, which has 
been used in ex vivo aortic ring assays (15) and in vitro endothelial tube formation (16), is 
another possibility.  It would be interesting to extend these studies by analyzing the actual 
ECM composition in the adventitia of normal and diseased arteries.  Knowing the relative 
levels of different matrix components, one could tailor an assay to better mimic the in vivo 
adventitial environment where AdvSca1 cells normally reside. 
 Other angiogenesis assays such as the corneal micropocket assay, the chick 
chorioallantoic membrane assay, and the rodent mesentery angiogenesis assay have both 
advantages and disadvantages (17, 18).  Given the range of mesenchymal cell potentials 
observed from AdvSca1 cells, it makes sense to move beyond an angiogenic environment 
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for additional in vivo assays.  The kidney capsule transplantation assay and denatured 
collagen sponge implant would be appropriate choices for testing AdvSca1 behavior in 
different environments.  In the kidney capsule transplantation model, cells or tissues are 
implanted in the subcapsular region of the kidney and allowed to differentiate.  The kidney is 
highly vascularized, and the capsule can physically accommodate a variety of tissue and 
cell types (19).  This system has the advantage of being unbiased towards a particular cell 
fate, as cells are not treated with exogenous factors.  Differentiation to tissues as diverse as 
bone and bone marrow (20), pancreatic beta-cells (21), and neural tissue (22) have been 
found in different uses of kidney capsule transplantation.  In contrast, the collagen sponge 
implant assay would be most useful for directed differentiation of AdvSca1 cells towards an 
osteogenic fate, which we have not yet observed in vivo.  In this model, isolated AdvSca1 
cells would be treated with BMP2 and mounted on a collagen sponge, which is implanted 
subcutaneously into a host mouse (23).  Both the kidney capsule and collagen sponge 
assays can be used with 106 or fewer cells and do not require prior cell culture, which is 
necessary for AdvSca1 cell assays.  
 
Hedgehog signaling and AdvSca1 regulation in vascular injury models 
 In our preliminary studies using the carotid artery flow reduction model of vascular 
injury and remodeling, we observed an expanded adventitial compartment at one week 
post-ligation, as has been previously reported (24).  The neoadventitia included expanded 
numbers of AdvSca1 cells, some of which were positive for the mitotic marker phospho-
histone H3 (pH3).  Hh pathway activity, as evaluated by X-gal staining for Ptc2-lacZ 
expression, was unchanged in the adventitia of flow-reduced vessels compared to sham 
controls.   These experiments will need to be expanded and refined, particularly to include 
earlier timepoints.  Godin et al. performed complete ligation of the common carotid artery 
and evaluated the proliferation index by BrdU incorporation at 1, 3, 7, 14, and 28 days.  At 
126 
one day post-ligation, they observed >20% BrdU-positive cells in the adventitia.  The rate of 
proliferation decreased sharply thereafter and reached baseline by one week (25).  It is 
likely, therefore, that we have missed the peak of adventitial cell proliferation by conducting 
our examination at one week post-ligation.  Furthermore, our data suggest that Shh 
signaling plays an important role in regulating AdvSca1 proliferation.  Analyzing gene 
expression changes at early timepoints, particularly with respect to Hh pathway 
components, will be a more reliable method of evaluating Hh pathway activation.   
 One area that has not been addressed in prior studies is whether the development of 
neoadventitia in vascular injury models is accompanied by a concomitant expansion of the 
vasa vasorum.  Non-diseased arteries in mice are generally thought to have an extremely 
limited vasa vasorum (26) yet our lab has been able to visualize adventitial microvessels 
using immunostaining and whole-mount confocal microscopy.  Several studies have 
reported that the vasa vasorum is greatly expanded in mouse models of atherosclerosis 
(26).  The vasa vasorum network functions to supply oxygen and nutrients to cells in the 
outer layers of the artery wall (27).  Expansion of the vasa vasorum following vascular injury 
could be a response to angiogenic factors released as a result of mechanical stress in the 
vessel wall or a reaction to hypoxia induced by increased artery wall thickness.  While an 
extensive investigation of these questions is not directly relevant to the concepts presented 
in this work, it is worth considering the possibility that any increases in adventitial Hh 
signaling following vascular injury may also promote vasa vasorum angiogenesis.  
Therefore, if Hh pathway activation is observed following carotid flow reduction or balloon 
injury, an evaluation of vasa vasorum density should also be conducted.  These 
experiments could be further expanded to include adventitial treatment with cyclopamine 
suspended in pluronic gel, in order to observe alterations in adventitial response to vascular 
injury when Hh pathway activation is blocked.   
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Regulation of the progenitor phenotype by Klf4 
 The results of our experiments involving Klf4 knockdown in AdvSca1 cells strongly 
suggest that Klf4 plays a critical role in regulating the progenitor phenotype.  However, it 
remains unresolved whether Klf4 actively promotes progenitor cell self-renewal, blocks the 
expression of smooth muscle genes, or both.  As we expand the scope of these 
experiments, gaining a better understanding of what constitutes the “progenitor phenotype” 
of AdvSca1 cells will be critical for interpreting experimental results.  Sca1 is an extremely 
useful marker for AdvSca1 cells, as it is a cell-surface protein not expressed by other 
adventitial cell types.  We currently isolate and evaluate the progenitor status of AdvSca1 
cells based on the presence or absence of Sca1 protein and gene expression.  
Nevertheless, the validity of this approach needs to be verified by examining other aspects 
of the AdvSca1 phenotype.  For example, as Sca1 expression is lost in response to Klf4 
knockdown, are other progenitor cell markers such as CD34 also downregulated?  A more 
extensive analysis of gene expression changes following Klf4 knockdown will not only be 
informative in giving us a wider view of global changes in the phenotype of AdvSca1 cells, 
but may provide clues as to the particular function of Klf4.   
 An evaluation of the AdvSca1 phenotype in KLF4 mutant mice will be a critical 
supplement to our in vitro experiments.  KLF4 knockout mice have been generated and 
characterized, and no obvious vascular defects were detected.  KLF4-/- mice are born in 
normal Mendelian ratios, but die within 15 hours after birth due to loss of skin barrier 
function (28).  These mice will be useful for basic analyses of AdvSca1 phenotype to identify 
abnormalities such as delayed appearance, reduced numbers, or altered distribution.  If 
AdvSca1 cells are present, they can be isolated for gene expression analysis and tested for 
in vitro and in vivo differentiation behavior.   
The siRNA experiments represent an acute loss of Klf4 expression, while the KLF4-/- 
mutant mice exhibit a constitutive absence of Klf4 function.  It will be interesting to compare 
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the effects of these two models on AdvSca1 cell phenotype.  In addition, evaluation of acute 
loss of Klf4 in vivo can be achieved through the use of floxed-KLF4 mice (29).  Until the 
development of an appropriate cre mouse to genetically target AdvSca1 cells, experiments 
would rely on conditional expression of globally-expressed cre.  Nonetheless, it would be 
informative to investigate the behavior of Klf4-deficient AdvSca1 cells in vivo without 
removing them from the native adventitial environment.  These experiments could be further 
expanded to analyze the response of Klf4-deficient AdvSca1 cells to various forms of 
vascular insult, including vascular injury models or genetic susceptibility to atherosclerosis.   
 To our knowledge, there have been no reports directly connecting Klf4 activity and 
signaling through the Hh pathway, although both have been linked to adipogenesis.  
Through a screen in Drosophila, Pospisilik et al. identified the Hh signaling pathway as an 
important regulator of adipocyte differentiation.  When suppressor of fused (Sufu) was 
deleted in adipose tissue, thus activating the Hh pathway, mutant mice displayed defective 
white adipocyte differentiation and a significant reduction in white adipose tissue (30).  In 
contrast, Klf4 has been reported to function as an immediate early regulator of adipogenesis 
through the direct transcriptional activation of C/EBPβ (31).  It will be interesting to evaluate 
any direct relationship between the Hh pathway and Klf4 in AdvSca1 cells, although it is 
important to consider that reciprocal regulatory effects may be mediated by cross-talk 
between multiple other signaling pathways. 
 
Additional modes of progenitor cell regulation 
 It is important to keep in mind that multiple other factors are likely to play significant 
roles in regulating the progenitor phenotype of AdvSca1 cells in situ.  Therefore, I will 
conclude with a brief discussion of two additional candidate regulators.   
Hypoxia:  Little has been reported regarding oxygen levels in normal arterial 
adventitia.  In animal models, hypoxic exposure induces rapid and dramatic changes in 
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adventitial architecture of pulmonary vessels.  These include adventitial fibroblast 
proliferation and changes in ECM protein synthesis (32).  Fibroblasts isolated from the main 
pulmonary artery adventitia upregulate SMα-actin when cultured in a hypoxic environment 
(33).  As with all previous literature addressing the behavior of adventitial “fibroblasts”, we 
question whether the observed cellular response is attributable to AdvSca1 cells, fibroblasts, 
or both.   
There have been numerous reports in the literature of environmental oxygen content 
modulating the behavior of different progenitor cell types.  Notably, Berthelemy et al. 
observed differential fates of circulating mononuclear cells when cultured under normoxic or 
hypoxic conditions.  Under normoxia, the cells displayed the morphology and markers of 
endothelial cells, while hypoxia induced expression of SMC markers (34).  Adipose stromal 
cells also modulate various aspects of their phenotype in response to hypoxia (35-37).  
Interestingly, Sims et al. reported that Shh expression is upregulated following 
ischemic/hypoxic insult the brain, inducing neural progenitor cell proliferation (38).  Given 
these precedents, it would be very interesting to compare AdvSca1 behavior when cultured 
under standard conditions versus hypoxia.  Our preliminary data indicates AdvSca1 cells 
express key members of the hypoxia-inducible factor family, including HIF1α, HIF2α, and 
ARNT (HIF1β) (data not shown).  Observing changes in AdvSca1 proliferation or 
differentiation at different oxygen concentrations would suggest that oxygen levels are an 
important regulator of progenitor cell behavior in the adventitia. 
Chromatin conformation:  Previous studies have suggested that histone 
modifications such as acetylation play a role in the regulation of SMC gene transcription (39-
43).  The ability of SRF to activate transcription of SMC marker genes depends on its ability 
to recognize and bind CArG box elements found in promoter and intronic locations.  Histone 
tail modifications can change the structure of chromatin, thus impacting the ability of 
transcription factors to recognize and bind target sites.  Chromatin structure and accessibility 
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of target genes are regulated by the opposing activities of histone acetyltransferases (HATs) 
and histone deacetylases (HDACs).  Chromatin immunoprecipitation (ChIP) analysis in 
cultured SMCs has shown that acetylated histones H3 and H4 are associated with the 
SMαA, SM22α, and SM-MHC gene regulatory regions (39, 40).  McDonald et al showed 
enrichment of the activating modifications H3K4dMe, H3K79dMe, H3K9Ac, and H4Ac at 
CArG box chromatin in SMCs versus other cells types, including embryonic stem cells, 
endothelial cells, and undifferentiated A404 cells (42).  Currently, however, little is known 
about the epigenetic regulation of SMC progenitors in vivo and how histone modifications 
may be altered as these cells differentiate and express SMC marker genes for the first time.  
Our preliminary data indicates that AdvSca1 cells express HDACs 1, 2, and 5 (data not 
shown), histone modifying enzymes which are known to interact with Klf4 (42, 44, 45).  
Given that AdvSca1 cells express SRF and known co-activators of SMC marker gene 
transcription, it will be very interesting to evaluate the status of CArG elements in AdvSca1 
cells.  Coimmunoprecipitation and ChIP techniques can be used to address the status of 
SRF-CArG occupancy, SRF-Klf4 interaction, Klf4-HDAC interaction, and CArG element 
histone modifications in AdvSca1 cells before and after in vitro differentiation. 
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Appendix A:  Supplementary Figures 
 
 
 
 
 
 
Supplemental Figure 1.  Other potential fates of AdvSca1 cells in vivo.  Isolated AdvSca1 
cells expressing membrane-localized tdTomato fluorescent protein were incubated in 
Matrigel plugs with 0.5 µg/mL human FGF2 and 60 U/mL heparin for 10 d.  Single confocal 
Z-sections indicate tdTomato co-localization with PECAM (arrowheads, A), perilipin, a 
marker of adipocytes (B), and CD68, a marker of macrophages (C).   
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Supplemental Figure 2.  Whole-mount views of AdvSca1 cells in the artery wall.  The left 
carotid artery of a wild-type mouse was stained for Sca1 expression and evaluated by 
confocal microscopy.  Views from different angles (A-C) show AdvSca1 cells localized to the 
adventitia, where they display a slightly flattened morphology.  Data shown was generated 
by Virginia Hoglund.   
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Supplemental Figure 3.  Downregulation of Hh pathway components during SMC 
differentiation.  The A404 cell line was developed from P19 mouse embryonal carcinoma 
cells as described by Blank et al. (1).  Treatment with retinoic acid (RA) induces SMC 
differentiation.  RNA was isolated from undifferentiated (U) cells, cells at day 3 (D3), and 
cells at day 5 (D5) of RA-induced SMC differentiation and the expression of SMC marker 
genes and Hh pathway components was evaluated by RT-PCR.  As A404 cells undergo 
SMC differentiation, multiple Hh pathway components are downregulated.  A similar trend 
was observed during the ex vivo differentiation of proepicardial cells (data not shown).  Data 
shown was generated by Chang Su.   
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Appendix B:  List of Primer Sequences 
 
Gene Forward Primer Reverse Primer Product Size Reference 
β-actin TGTTACCAACTGGGACGACA CTCTCAGCTGTGGTGGTGAA 393 (1) 
Boc CCCAGAAGCTCCAGACAGAC TGTCCCCTTCTACCATGTCC 500  
Calponin CACCAACAAGTTTGCCAG TGTGTCGCAGTGTTCCAT 213 (2) 
CD140b 
(PDGFR-
β) 
AGCTACATGGCCCCTTATGA GGATCCCAAAAGACCAGACA 367  
CD34 TTGACTTCTGCAACCACGGA TAGATGGCAGGCTGGACTTC 300 (3) 
Cdo AGGGGAGAGTGAGTTCAGCA CCTGGTCAGGGAGTTTGTGT 493  
Csrp1 AGTCTCTGGGCATCAAGCAT CCGCTGATGAAAAGCTTAGG 376  
Csrp2 GCATGGTTTGCAGGAAAAAT CCCACACCTGGAACACTTCT 260  
Dhh ATGCCCAATTGACAGGAGAG GGCCTTCGTAGTGGAGTGAA 500  
Disp1 CAAGAGGGACCACGATAGGA GTGCCGTTTTGGTAGTGCTT 505  
Flk1 TCTGTGGTTCTGCGTGGAGA GTATCATTTCCAACCACCCT 270 (3) 
Foxo4 TGTAACAGGTCCTCGGAAGG GACAGACGGCTTCTTCTTGG 394  
Gli1 TGGAAGGGGACATGTCTAGC ATGGCTTCTCATTGGAGTGG 501  
Gli2 CCTCCAACCTCAACAAGAGC CTGCAGGAGGGAGAAAACTG 403  
Gli3 CCGTTCAAAGCCCAGTACAT TCTTCACCTGGAGGCACTCT 505  
Hhip CCGTGGATCGACATCCTACT GGGCAGGTTGAACTGTGACT 498  
Ihh GGCCATCACTCAGAGGAGTC ATATTGGCCTGGTTGCACAT 501  
Kit GGCTCATAAATGGCATGCTC CTTCCATTGTACTTCATACATG 400 (3) 
Klf2 ACCAAGAGCTCGCACCTAAA CAGAACTGGTGGCAGAGTCA   
Klf4 ATTAATGAGGCAGCCACCTG GGAAGACGAGGATGAAGCTG 400  
Klf5 GTCTGCGGTTTAAAGGATGG GCCAGTTAATTCGCCAACTC   
MRTF-A CCAGGCTGGCTGATGACCTCAATG CTGTGATTTCTCGCTGGCAGACTTG 473 (2) 
MRTF-B ACCCCAGCAGTTTGTTGTTC TGGAATGACTCAGCAAGTCG 488  
Msx1 GCTGGAGAAGCTGAAGATGG AGGGGTCAGATGAGGAAGGT 391  
Msx2 AGACATATGAGCCCCACCAC GGGAGCACAGGTCTATGGAA 365  
Myocardin ATGCACCAAACACACCTCAA GCTGCCAAAGTGGTAGAAGC 384  
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Ptc1 CATTGGCAGGAGGAGTTGAT CCTGAGTTGTCGCAGCATTA 499  
Ptc2 TCCCCCAGAGCTCTTCTACA GGGATGGCACTCAGTTTGAT 501  
Sca1 CTCGAGGATGGACACTTCT GGTCTGCAGGAGGACTGAGC 400  
Shh TCTGTGATGAACCAGTGGCC GCCACGGAGTTCTCTGCTTT 241 (4) 
SM α-
Actin 
ACGGCCGCCTCCTCTTCCTC GCCCAGCTTCGTCGTATTCC 415  
SM-MHC GACAACTCCTCTCGCTTTGG GCTCTCCAAAAGCAGGTCAC 201 (5) 
SM22α TCCAGTCCACAAACGACCAAGC GAATTGAGCCACCTGTTCCATCTG 328 (6) 
Smo GGCTGGAGTAGTCTGGTTCG TGGCTTGGCATAGCACATAG 500  
SRF CTACCAGGTGTCGGAATCTGA CCAGACGGTGCTGTCAGGAACA 651 (2) 
Sufu CAAAGGCATTGAGACAGACG GCATACGGGTGTTCCTCAGT 507  
 
 
 
 
 
References 
 
1. Kume, T., Jiang, H., Topczewska, J.M., and Hogan, B.L. 2001. The murine winged 
helix transcription factors, Foxc1 and Foxc2, are both required for cardiovascular 
development and somitogenesis. Genes Dev 15:2470-2482. 
2. Brunelli, S., Tagliafico, E., De Angelis, F., Tonlorenzi, R., Baesso, S., Ferrari, S., 
Niinobe, M., Yoshikawa, K., Schwartz, R., Bozzoni, I., et al. 2004. Msx2 and necdin 
combined activities are required for smooth muscle differentiation in mesoangioblast 
stem cells. Circ Res 94:1571-1578. 
3. Minasi, M.G., Riminucci, M., De Angelis, L., Borello, U., Berarducci, B., Innocenzi, A., 
Caprioli, A., Sirabella, D., Baiocchi, M., De Maria, R., et al. 2002. The meso-
angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and 
differentiates into most mesodermal tissues. Development 129:2773-2783. 
4. Krebs, O., Schreiner, C.M., Scott, W.J., Jr., Bell, S.M., Robbins, D.J., Goetz, J.A., 
Alt, H., Hawes, N., Wolf, E., and Favor, J. 2003. Replicated anterior zeugopod (raz): 
a polydactylous mouse mutant with lowered Shh signaling in the limb bud. 
Development 130:6037-6047. 
5. Hu, Y., Zhang, Z., Torsney, E., Afzal, A.R., Davison, F., Metzler, B., and Xu, Q. 2004. 
Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts 
in ApoE-deficient mice. J Clin Invest 113:1258-1265. 
6. Sinha, S., Hoofnagle, M.H., Kingston, P.A., McCanna, M.E., and Owens, G.K. 2004. 
Transforming growth factor-beta1 signaling contributes to development of smooth 
muscle cells from embryonic stem cells. Am J Physiol Cell Physiol 287:C1560-1568. 
 140 
Appendix C:  List of Antibodies 
 
 
Antigen Supplier (Catalog #) Method Notes (as differ from text) 
β-galactosidase MP Biomedical (55976)  
Shh R&D Systems (AF445)  
SM-MHC Biomedical Technologies (BT-562)  
SMαA Sigma (A2547) best with methanol or methanol/acetone fixation/permeabilization 
Sca1 BD Pharmingen (553333) does not require permeabilization, not compatible with Triton X-100 treatment 
PECAM-1 BD Pharmingen (550274)  
BrdU BD Pharmingen (555627)  
SRF Santa Cruz Biotechnology (sc335)  
FLAG Sigma (F1804) requires permeabilization 
GFP Abcam (ab13970)  
 
 
